azathioprine has been researched along with Autoimmune Chronic Hepatitis in 333 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report a case of acute severe hepatitis resulting from masitinib in a young amyotrophic lateral sclerosis patient." | 7.81 | Autoimmune-like hepatitis during masitinib therapy in an amyotrophic lateral sclerosis patient. ( Camacho, J; Gamez, J; Salvado, M; Simon-Talero, M; Vargas, V; Vidal, M, 2015) |
| "Azathioprine induced pancreatitis usually runs a benign self limited course with rapid disappearance of signs and symptoms upon with drawl of the drug." | 7.77 | Azathioprine induced pancreatitis in a patient with co-existing autoimmune pancreatitis and hepatitis. ( Navaneethan, U; Venkatesh, PG, 2011) |
| "Sporadic descriptions of acute onset of watery diarrhea within a few hours to a few weeks azathioprine administration beginning have been reported, particularly in inflammatory bowel disease patients." | 7.74 | Acute diarrhea during azathioprine treatment of type I autoimmune hepatitis. ( Foti, M; Fracchia, M; Galatola, G; Pera, A; Tabone, M, 2008) |
| "The use of azathioprine (AZA) in the treatment of autoimmune diseases during pregnancy are believed to be relatively safe, particularly taking into account the potential risks for mother and fetus should the underlying disease become active due to withdrawal of this thiopurine." | 7.73 | Azathioprine use during pregnancy: unexpected intrauterine exposure to metabolites. ( de Boer, NK; de Graaf, P; Jarbandhan, SV; Mulder, CJ; van Bodegraven, AA; van Elburg, RM, 2006) |
| "Many of these lymphomas are associated with Epstein-Barr virus (EBV), which might be reactivated under immunosuppression." | 5.48 | Azathioprine-induced reversible EBV-associated Hodgkin-like lymphoma after immunosuppressive therapy for autoimmune hepatitis . ( Birkmann, J; Holzgrabe, U; Munz, M; Pretscher, D; Sörgel, F; Wilhelm, M, 2018) |
| "Azathioprine is a widely used immunosuppressive drug." | 5.39 | Azathioprine-induced fever in autoimmune hepatitis. ( Chen, S; Khoury, T; Mizrahi, M; Ollech, JE; Shalit, M, 2013) |
| "Azathioprine was considered responsible for these two adverse reactions (shock) as an allergen." | 5.31 | [Autoimmune hepatitis complicated by intolerable pain of lower extremities and shock due to azathioprine]. ( Kawano, F; Kiyokawa, T; Sanada, I; Tsukamoto, A, 2000) |
| "We report the first 2 cases of hepatosplenic T-cell lymphoma in adolescents diagnosed with autoimmune hepatitis under long-term treatment with azathioprine." | 3.83 | Two Cases of Hepatosplenic T-Cell Lymphoma in Adolescents Treated for Autoimmune Hepatitis. ( Arrenberg, P; Brinkert, F; Grabhorn, E; Krech, T; Lohse, A; Schramm, C, 2016) |
| "We report a case of acute severe hepatitis resulting from masitinib in a young amyotrophic lateral sclerosis patient." | 3.81 | Autoimmune-like hepatitis during masitinib therapy in an amyotrophic lateral sclerosis patient. ( Camacho, J; Gamez, J; Salvado, M; Simon-Talero, M; Vargas, V; Vidal, M, 2015) |
| "Azathioprine induced pancreatitis usually runs a benign self limited course with rapid disappearance of signs and symptoms upon with drawl of the drug." | 3.77 | Azathioprine induced pancreatitis in a patient with co-existing autoimmune pancreatitis and hepatitis. ( Navaneethan, U; Venkatesh, PG, 2011) |
| " Before conception and in early pregnancy, azathioprine and prednisone were administered in 48." | 3.75 | Follow-up of pregnant women with autoimmune hepatitis: the disease behavior along with maternal and fetal outcomes. ( Abrantes-Lemos, CP; Cançado, EL; Carrilho, FJ; Terrabuio, DR, 2009) |
| " For primary biliary cirrhosis, ursodeoxycholic acid is safe and is the first choice for treatment." | 3.74 | Guidelines for therapy of autoimmune liver disease. ( Gershwin, ME; Ishibashi, H; Komori, A; Shimoda, S, 2007) |
| "Sporadic descriptions of acute onset of watery diarrhea within a few hours to a few weeks azathioprine administration beginning have been reported, particularly in inflammatory bowel disease patients." | 3.74 | Acute diarrhea during azathioprine treatment of type I autoimmune hepatitis. ( Foti, M; Fracchia, M; Galatola, G; Pera, A; Tabone, M, 2008) |
| " Azathioprine has a significant early adverse reaction (EAR) profile, which includes an acute syndrome of constitutional symptoms, fever, rash, and acute pancreatitis and often requires discontinuation of drug." | 3.73 | Increased rates of early adverse reaction to azathioprine in patients with Crohn's disease compared to autoimmune hepatitis: a tertiary referral center experience. ( Bajaj, JS; Binion, DG; Emmons, J; Franco, J; Knox, JF; Levy, M; Podoll, J; Saeian, K; Varma, RR, 2005) |
| "The use of azathioprine (AZA) in the treatment of autoimmune diseases during pregnancy are believed to be relatively safe, particularly taking into account the potential risks for mother and fetus should the underlying disease become active due to withdrawal of this thiopurine." | 3.73 | Azathioprine use during pregnancy: unexpected intrauterine exposure to metabolites. ( de Boer, NK; de Graaf, P; Jarbandhan, SV; Mulder, CJ; van Bodegraven, AA; van Elburg, RM, 2006) |
| "The disease of 9 years' duration did not relapse during pregnancy under continuous treatment with steroids, cytotoxic drugs, ursodeoxycholic acid and vitamins." | 3.72 | [Autoimmune hepatitis during pregnancy]. ( Blickstein, I; Kruchkovich, J, 2003) |
| "The goal of autoimmune hepatitis treatment is to achieve clinical and biochemical remission, which is associated with significantly improved outcomes." | 3.54 | Treatment of Autoimmune Hepatitis. ( Goel, A; Kwo, P, 2024) |
| " Secondary outcomes include safety and tolerability of MMF and azathioprine, time to remission, changes in Model For End-Stage Liver Disease (MELD)-score, adverse events, and aspects of quality of life." | 3.11 | Assessing the efficacy and safety of mycophenolate mofetil versus azathioprine in patients with autoimmune hepatitis (CAMARO trial): study protocol for a randomised controlled trial. ( Bakker, SF; Bartelink, M; Beuers, UHW; Biewenga, M; de Boer, YS; de Jonge, HJM; Drenth, JPH; Gevers, TJG; Gisbertz, IAM; Guichelaar, MMJ; Levens, AD; Pape, S; Pronk, MAMCB; Sebib Korkmaz, K; Sijtsma, MGM; Snijders, RJALM; Soufidi, K; Stoelinga, AEC; van den Berg, AP; van den Brand, FF; van der Meer, AJ; van Gerven, NMF; van Hoek, B; Vanwolleghem, T; Verdonk, RC; Verwer, BJ; Vrolijk, JM, 2022) |
| " Biomarkers that can predict the clinical course of disease, identify patients at elevated risk for relapse, and improve monitoring and medication dosing beyond current practice would have high clinical value." | 2.82 | Noninvasive biomarkers for the diagnosis and management of autoimmune hepatitis. ( Assis, DN; Cravedi, P; Harrington, C; Krishnan, S; Levitsky, J; Mack, CL, 2022) |
| "Autoimmune hepatitis is a chronic inflammatory disease of the liver." | 2.82 | Autoimmune hepatitis: Challenges and novelties. ( Londoño, MC; Olivas, I; Rodríguez-Tajes, S, 2022) |
| "The prednisone dose was weaned in three of four subjects, with one subject flaring after steroid withdrawal." | 2.78 | Rituximab for the treatment of patients with autoimmune hepatitis who are refractory or intolerant to standard therapy. ( Aspinall, AI; Burak, KW; Coffin, CS; Lee, SS; Myers, RP; Santodomingo-Garzon, T; Santodomino-Garzon, T; Swain, MG; Urbanski, SJ, 2013) |
| "Autoimmune liver diseases (autoimmune hepatitis, primary sclerosing cholangitis, overlap syndrome) can occur in the setting of limited symptoms; therefore, a high index of suspicion and appropriate diagnostic workup should be performed." | 2.72 | Pediatric Autoimmune Liver Diseases: Autoimmune Hepatitis and Primary Sclerosing Cholangitis. ( Kemme, S; Mack, CL, 2021) |
| " In the future, the quality of life of AIH patients should be managed by personalized medicine, including the appropriate selection and dosing of first-line therapy and perhaps alternating with potential therapeutics, and the prediction of the success of treatment withdrawal." | 2.72 | Recent updates on the management of autoimmune hepatitis. ( Komori, A, 2021) |
| "Management guidelines on autoimmune hepatitis should be extended to emphasize that changes in hepatic metabolic function, as well as ALT and gamma-globulin levels, be taken into consideration in the definition of remission." | 2.71 | How reversible is hepatic functional impairment in autoimmune hepatitis? ( Coverdale, SA; Farrell, GC; Field, J, 2003) |
| "Tacrolimus treatment was safe and well tolerated." | 2.71 | Efficacy of tacrolimus in the treatment of steroid refractory autoimmune hepatitis. ( Aqel, BA; Dickson, RC; Harnois, DM; Machicao, V; Rosser, B; Satyanarayana, R, 2004) |
| "Azathioprine has been used for many years, with corticosteroids or alone, for the treatment of autoimmune hepatitis (AIH) but no studies of TPMT phenotype and genotype in relation to response to the drug in AIH have been published." | 2.70 | Thiopurine methyltransferase phenotype and genotype in relation to azathioprine therapy in autoimmune hepatitis. ( Langley, PG; McFarlane, IG; Norris, S; Tredger, JM; Underhill, J, 2002) |
| " Dose-restricted tioguanine (thioguanine) could expand treatment options by reducing methylated metabolites, increasing the bioavailability of 6-tioguanine nucleotides and ameliorating thiopurine intolerance or resistance." | 2.66 | Review article: opportunities to improve and expand thiopurine therapy for autoimmune hepatitis. ( Czaja, AJ, 2020) |
| "Autoimmune hepatitis is a rare and chronic liver disease that is characterised by increased serum transaminases and immunoglobulin G, inflammatory liver histology and presence of circulating autoantibodies." | 2.61 | Clinical management of autoimmune hepatitis. ( Gevers, TJ; Pape, S; Schramm, C, 2019) |
| "Autoimmune hepatitis is a corticosteroid-responsive liver disease arising consequent to immunogenetic and environmental risk factors." | 2.61 | Grand round: Autoimmune hepatitis. ( Gleeson, D; Heneghan, M; Hirschfield, GM; Hubscher, SG; Trivedi, PJ, 2019) |
| "Initial treatment of autoimmune hepatitis (AIH) with prednisolone ± azathioprine is based on randomised controlled trials." | 2.61 | Stopping immunosuppressive treatment in autoimmune hepatitis (AIH): Is it justified (and in whom and when)? ( Gleeson, D; Harrison, L, 2019) |
| "First-line treatment for autoimmune hepatitis (AIH) typically includes corticosteroids in combination with azathioprine." | 2.61 | Systematic review with meta-analysis: mycophenolate mofetil as a second-line therapy for autoimmune hepatitis. ( Levy, C; Santiago, P; Schwartz, I; Tamariz, L, 2019) |
| "Autoimmune hepatitis is a chronic inflammatory liver disease." | 2.58 | Autoimmune hepatitis: From current knowledge and clinical practice to future research agenda. ( Hartl, J; Lohse, AW; Sebode, M; Vergani, D, 2018) |
| "De novo autoimmune hepatitis (AIH) is an unusual cause of graft dysfunction after liver transplantation." | 2.58 | De novo autoimmune hepatitis -is this different in adults compared to children? ( Kerkar, N; Vergani, D, 2018) |
| "Ten percent to 20% of children with autoimmune hepatitis (AIH) require second-line therapy to achieve remission." | 2.55 | Second-line Agents in Pediatric Patients With Autoimmune Hepatitis: A Systematic Review and Meta-analysis. ( Kamath, BM; Shah, PS; Valentino, PL; Zizzo, AN, 2017) |
| "Autoimmune hepatitis is a rare chronic inflammatory liver disease, affecting all ages, characterised by elevated transaminase and immunoglobulin G levels, positive autoantibodies, interface hepatitis at liver histology and good response to immunosuppressive treatment." | 2.55 | Autoimmune hepatitis: Standard treatment and systematic review of alternative treatments. ( Mieli-Vergani, G; Terziroli Beretta-Piccoli, B; Vergani, D, 2017) |
| "Autoimmune hepatitis is characterized by autoantibodies, hypergammaglobulinemia, and interface hepatitis on histological examination." | 2.53 | Diagnosis and Management of Autoimmune Hepatitis: Current Status and Future Directions. ( Czaja, AJ, 2016) |
| "The International Autoimmune Hepatitis Group (IAIHG) has devised diagnostic scoring systems to help in comparative studies and clinical practice." | 2.53 | Cutting edge issues in autoimmune hepatitis. ( Krawitt, EL; Liberal, R; Manns, MP; Mieli-Vergani, G; Vergani, D; Vierling, JM, 2016) |
| "Autoimmune hepatitis is a chronic immune-mediated liver injury, frequently associated with progression to end-stage liver disease if untreated." | 2.52 | Autoimmune hepatitis: an approach to disease understanding and management. ( Adams, DH; Corrigan, M; Hirschfield, GM; Oo, YH, 2015) |
| "Most reports on APF suggest systemic lupus erythematosus (SLE) as the major immunological associated disorder but the association with autoimmune hepatitis (AH) has not been previously documented." | 2.49 | Amicrobial pustulosis of the folds associated with autoimmune disorders: systemic lupus erythematosus case series and first report on the association with autoimmune hepatitis. ( Charli-Joseph, Y; Fernández Sánchez, M; Méndez-Flores, S; Orozco-Topete, R; Saeb-Lima, M, 2013) |
| "Immunoglobulin G4 (IgG4)-associated autoimmune hepatitis (AIH) was recognized as a new disease entity; however, IgG4-associated de novo AIH after the liver transplantation had not been reported yet." | 2.49 | Immunoglobulin G4-associated de novo autoimmune hepatitis after liver transplantation for chronic hepatitis B- and C-related cirrhosis and hepatocellular carcinoma: a case report with literature review. ( Jia, JD; Rakhda, MI; Wang, TI; Zhao, XY, 2013) |
| "Autoimmune hepatitis has a global distribution affecting any age, both sexes and all ethnic groups." | 2.49 | Review article: autoimmune hepatitis -- current management and challenges. ( Dalekos, GN; Fabbri, A; Gatselis, N; Granito, A; Koukoulis, GK; Muratori, L; Muratori, P; Zachou, K, 2013) |
| "Autoimmune hepatitis is an immune-mediated disease targeting hepatocytes." | 2.48 | The treatment of autoimmune hepatitis. ( Basevitz, A; Duek, G; Malnick, S; Melzer, E, 2012) |
| "Unlike other autoimmune liver diseases, primary biliary cirrhosis (PBC) has never been reported in early childhood, while type 2 autoimmune hepatitis (AIH) is eminently a paediatric disease." | 2.48 | Autoimmune hepatitis type 2 associated with an unexpected and transient presence of primary biliary cirrhosis-specific antimitochondrial antibodies: a case study and review of the literature. ( Alessio, MG; Bogdanos, DP; Candusso, M; Fabris, L; Invernizzi, P; Iorio, R; Lleo, A; Smyk, DS; Sonzogni, A; Torre, G, 2012) |
| " Adequately dosed steroids are the mainstay of remission induction treatment, while remission maintenance is best achieved by azathioprine." | 2.47 | Autoimmune hepatitis. ( Lohse, AW; Mieli-Vergani, G, 2011) |
| "Without prompt immunosuppressive treatment, autoimmune hepatitis is a devastating, albeit rare, liver disease." | 2.47 | Pharmacological management of autoimmune hepatitis. ( Mieli-Vergani, G; Vergani, D, 2011) |
| "Autoimmune hepatitis is a chronic inflammatory disease of the liver with a dismal prognosis when left untreated." | 2.46 | Autoimmune hepatitis. ( Strassburg, CP, 2010) |
| "The treatment of autoimmune hepatitis is evolving as the pathogenic pathways that underlie the disease are defined, new immunosuppressive agents are tested, and site-specific molecular interventions become feasible." | 2.44 | Current therapy for autoimmune hepatitis. ( Czaja, AJ; Montano Loza, AJ, 2007) |
| "Autoimmune hepatitis affects all ages, and it is probably under-diagnosed in the elderly." | 2.44 | Clinical features, differential diagnosis and treatment of autoimmune hepatitis in the elderly. ( Czaja, AJ, 2008) |
| " Individualized dosing schedules and the emergence of non-steroidal medications are realistic expectations." | 2.44 | Safety issues in the management of autoimmune hepatitis. ( Czaja, AJ, 2008) |
| "The use of corticosteroids in autoimmune hepatitis is an established therapy." | 2.43 | Promising treatment of autoimmune hepatitis with 6-thioguanine after adverse events on azathioprine. ( Aparicio Pages, MN; de Boer, NK; de Boer, SY; Derijks, LJ; Mulder, CJ; van Nieuwkerk, CM, 2005) |
| "In > 80% of patients with autoimmune hepatitis, steroid therapy alone or in combination with azathioprine results in disease remission." | 2.43 | Cost-effectiveness of pharmacotherapy for autoimmune hepatitis. ( Al-Chalabi, T; Heneghan, MA; McFarlane, IG, 2006) |
| "Autoimmune hepatitis is a chronic inflammatory liver disease that responds well to prednisone alone or in combination with azathioprine." | 2.42 | Autoimmune hepatitis. Making sense of all those antibodies. ( Luxon, BA, 2003) |
| "Autoimmune Hepatitis (AIH), primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC) and overlap syndromes of these three disease entities are regarded as autoimmune liver diseases." | 2.42 | [Autoimmune liver disease: diagnosis and therapy]. ( Bayer, EM; Kanzler, S; Lohse, AW; Schramm, C, 2004) |
| "Autoimmune Hepatitis (AIH), primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) represent acute and chronic inflammatory liver diseases in which immune reactions against host antigens are found to be the major pathological mechanism." | 2.41 | [Autoimmune hepatitis and overlap syndrome: therapy]. ( Löhr, HF, 2002) |
| "A case of autoimmune hepatitis (AIH) complicated by primary sclerosing cholangitis (PSC) in a 36-year-old woman is reported." | 2.41 | Autoimmune hepatitis overlapping with primary sclerosing cholangitis. ( Funabashi, Y; Kasukawa, R; Kumakawa, H; Ohira, H; Rai, T; Sato, Y; Shishido, S; Takiguchi, J; Tojo, J; Watanabe, H, 2002) |
| "The patient was diagnosed with autoimmune hepatitis and responded well to treatment with immunosuppressive drugs." | 2.41 | [Autoimmune hepatitis caused by acute hepatitis due to hepatitis A virus]. ( Belda Abad, G; Correa Estañ, JA; Hostalet Robles, F; Muñoz Bertrán, E; Muñoz Ramírez, E; Rosa Salazar, V, 2002) |
| "Prednisone alone or a lower dose of prednisone in combination with azathioprine induces remission and enhances survival in autoimmune hepatitis." | 2.41 | Emerging treatments for autoimmune hepatitis. ( Czaja, AJ, 2002) |
| "The diagnosis and management of autoimmune hepatitis continues to evolve as new diagnostic tests and new therapies are added to the armamentarium." | 2.41 | Autoimmune liver disease. Current standards, future directions. ( Gish, RG; Mason, A, 2001) |
| "Autoimmune hepatitis has a global distribution and affects all ages." | 2.41 | Current concepts in the diagnosis, pathogenesis, and treatment of autoimmune hepatitis. ( Al-Khalidi, JA; Czaja, AJ, 2001) |
| "Overlap syndrome is the combination of autoimmune liver diseases, and this term usually describes the coexistence of autoimmune hepatitis (AIH) and primary biliary cirrhosis (PBC) in the same patient." | 1.91 | Coexistence of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome and membranous nephropathy: A case report. ( Chen, H; Gao, X; Hong, X; Hu, S; Jin, X; Qiao, Z; Xia, C; Xiang, X; Xu, Y; Zhang, P, 2023) |
| "Dengue is a proven risk factor for many autoimmune conditions but its association with AIH is not studied." | 1.91 | Autoimmune hepatitis unmasked by dengue infection - An unexplored and rare association. ( Chaitanya, V; Jagtap, AB; Lall, B; Porwal, YC; S, C, 2023) |
| "In children with autoimmune hepatitis, uncertainties include outcomes associated with type 2 hepatitis, the possibility of and criteria for attempting withdrawal of treatment, and long-term outcomes." | 1.91 | Long-term outcomes of patients with type 1 or 2 autoimmune hepatitis presenting in childhood. ( Ballot, E; Bernard, O; Jacquemin, E; Johanet, C; Maggiore, G; Mosca, A, 2023) |
| "Mortality rates for autoimmune hepatitis (AIH) vary." | 1.91 | Long-term Outcome of Autoimmune Hepatitis: Consecutive Patient Cohort and Data on the Second Twenty Years. ( Dhaliwal, H; Dube, A; Gleeson, D; Harrison, L; Hoeroldt, B; Wadland, E, 2023) |
| "Autoimmune hepatitis was managed according to guidelines, except for the use of budesonide in a small proportion of paediatric patients." | 1.91 | Epidemiology, clinical features and management of autoimmune hepatitis in Switzerland: a retrospective and prospective cohort study. ( Becker, B; Bernsmeier, C; Böhm, S; Braegger, C; Bresson-Hadni, S; Cerny, A; Cremer, M; De Gottardi, A; Di Bartolomeo, C; Filipowicz Sinnreich, M; Furlano, R; Galante, A; Heyland, K; Kremer, AE; Limoni, C; Ludz, C; McLin, V; Mertens, J; Mieli-Vergani, G; Müller, P; Nydegger, A; Posovszky, C; Righini-Grunder, F; Rock, N; Semela, D; Sokollik, C; Stirnimann, G; Terziroli Beretta-Piccoli, B; Vergani, D, 2023) |
| "Autoimmune hepatitis is a rare but chronic autoimmune-mediated liver disease." | 1.72 | [Autoimmune Hepatitis - What is important for clinical practice?] ( Böttler, T; Thimme, R; Vogelbacher, L, 2022) |
| "Most patients with autoimmune hepatitis (AIH) respond to a combination of prednisolone and azathioprine." | 1.62 | Long-term outcome of patients with difficult-to-treat autoimmune hepatitis receiving mycophenolate mofetil. ( Gaspar, R; Liberal, R; Lopes, S; Macedo, G, 2021) |
| "Although standard treatment for autoimmune hepatitis (AIH) comprises prednisolone (PSL) and azathioprine (AZA), some patients are intolerant to or do not respond to PSL and/or AZA." | 1.62 | [Second-line therapy with mycophenolate mofetil in patients with autoimmune hepatitis who were intolerant or failed to respond to standard treatment]. ( Abe, K; Aiso, M; Aoyagi, H; Arizumi, T; Asaoka, Y; Isono, A; Kodashima, S; Matsumoto, K; Miki, A; Miura, R; Tachizawa, N; Tanaka, A; Yagi, M; Yamamoto, T, 2021) |
| "Therapy for autoimmune hepatitis (AIH) consists of steroid induction therapy, followed by maintenance therapy with azathioprine." | 1.56 | Profiling the patient with autoimmune hepatitis on calcineurin inhibitors: a real-world-experience. ( Drenth, JPH; Mertens, C; Nevens, F; Pape, S; Tjwa, ETTL; Verslype, C, 2020) |
| "Guidelines regarding treatment for autoimmune hepatitis (AIH) favour two strategies for azathioprine (AZA) introduction: concurrent with steroids at induction or delayed by 2-4 weeks." | 1.56 | High discontinuation rate of azathioprine in autoimmune hepatitis, independent of time of treatment initiation. ( Bouma, G; Drenth, JPH; Efe, C; Gevers, TJG; Hartl, J; Heneghan, MA; Jaeckel, E; Kahraman, A; Kessener, DJN; Lohse, AW; Manns, MP; Nevens, F; Ozaslan, E; Pape, S; Papp, M; Purnak, T; Schramm, C; Sipeki, N; Stickel, F; Taubert, R; van Hoek, B; van Nieuwkerk, CMJ; Vrolijk, JM; Wedemeyer, H, 2020) |
| "To compare the early biochemical response and rate of adverse effects in patients who received prednisolone (PRED)/azathioprine (AZA) and those who received budesonide (BUD)/AZA as the first-line treatment for autoimmune hepatitis." | 1.51 | The efficacy and adverse effects of budesonide in remission induction treatment of autoimmune hepatitis: a retrospective study. ( Binicier, OB; Günay, S, 2019) |
| "Data on rescue treatment of autoimmune hepatitis in patients that fail standard treatment are sparse." | 1.51 | Mycophenolate mofetil treatment in patients with autoimmune hepatitis failing standard therapy with prednisolone and azathioprine. ( Almer, S; Friis-Liby, IL; Giannakopoulos, G; Nyhlin, N; Sangfelt, P; Verbaan, H, 2019) |
| "Cyclosporine (CSA) is an alternative treatment for autoimmune hepatitis (AIH), however, its unknown long-term safety and efficacy have limited its use." | 1.51 | Long-term follow-up of children and young adults with autoimmune hepatitis treated with cyclosporine. ( Cirillo, F; Maggiore, G; Malaventura, C; Matarazzo, L; Nastasio, S; Riva, S; Sciveres, M, 2019) |
| "Development of autoimmune hepatitis (AIH) has been sporadically reported in patients with multiple sclerosis (MS) either concurrently or after treatment with immunomodulatory drugs, including interferon-beta (IFN-β) and steroids." | 1.51 | Autoimmune hepatitis in patients with multiple sclerosis: The role of immunomodulatory treatment. ( Arvaniti, P; Dalekos, GN; Gyftaki, S; Hadjigeorgiou, G; Koukoulis, GK; Rigopoulou, EI; Tsimourtou, V, 2019) |
| "Patients with autoimmune hepatitis (AIH) commonly receive induction therapy with predniso(lo)ne followed by maintenance therapy with azathioprine." | 1.51 | Predniso(lo)ne Dosage and Chance of Remission in Patients With Autoimmune Hepatitis. ( Belias, M; Bouma, G; Drenth, JPH; Gevers, TJG; Hartl, J; Heneghan, MA; Jaeckel, E; Lohse, AW; Manns, MP; Mustafajev, IF; Pape, S; Papp, M; Schramm, C; Stickel, F; Taubert, R; van Hoek, B; van Nieuwkerk, CMJ; Vrolijk, JM, 2019) |
| "A 15-year-old girl was diagnosed with influenza and prescribed 40 mg laninamivir." | 1.51 | Immune-mediated Drug-induced Liver Injury Caused by Laninamivir Octanoate Hydrate. ( Arinaga-Hino, T; Hirai, S; Ide, T; Kawaguchi, T; Nagamatsu, H; Shimizu, M; Takata, A; Tanikawa, K; Tateishi, H; Tokushige, T; Torimura, T, 2019) |
| "Many of these lymphomas are associated with Epstein-Barr virus (EBV), which might be reactivated under immunosuppression." | 1.48 | Azathioprine-induced reversible EBV-associated Hodgkin-like lymphoma after immunosuppressive therapy for autoimmune hepatitis . ( Birkmann, J; Holzgrabe, U; Munz, M; Pretscher, D; Sörgel, F; Wilhelm, M, 2018) |
| "PCA associated with autoimmune hepatitis-primary biliary cirrhosis (AIH-PBC) overlap syndrome and Sjögren syndrome (SS) has not been previously reported in the literature." | 1.48 | Primary cutaneous amyloidosis associated with autoimmune hepatitis-primary biliary cirrhosis overlap syndrome and Sjögren syndrome: A case report. ( Jin, J; Yan, X, 2018) |
| "The progression to liver cirrhosis or its complications was significantly less frequent in acute onset AIH (13% vs." | 1.48 | Clinical and prognostic implications of acute onset of Autoimmune Hepatitis: An Italian multicentre study. ( Bianchi, G; Carbone, M; Cazzagon, N; Floreani, A; Invernizzi, P; Lalanne, C; Lenzi, M; Muratori, L; Muratori, P; Perini, L; Ronca, V; Stangos, G, 2018) |
| "Despite advances in understanding and treatment of autoimmune hepatitis, important unmet clinical needs remain in both adult and paediatric patient populations." | 1.48 | Unmet needs and new models for future trials in autoimmune hepatitis. ( Jones, D; Manns, MP; Terracciano, L; Torbenson, M; Vierling, JM, 2018) |
| "The standard treatment for autoimmune hepatitis (AIH) is predniso(lo)ne for remission induction, tapered and followed by azathioprine, which effectively controls the disease in the majority of patients." | 1.46 | Enrichment of Genetic Variants in the Glucocorticoid Receptor Signalling Pathway in Autoimmune Hepatitis with Failure of Standard Treatment. ( Eriksen, PL; Grønbaek, H; Jessen, N; Kreutzfeldt, M; Thorsen, K; Vang, S; Vilstrup, H, 2017) |
| "Ascites, variceal bleeding, and hepatocellular carcinoma were found in 1." | 1.46 | Population-based prevalence, incidence, and disease burden of autoimmune hepatitis in South Korea. ( Choi, HY; Jang, ES; Jeong, SH; Ki, M; Kim, BH; Kim, KA, 2017) |
| "Beyond available guidelines, therapy of autoimmune hepatitis (AIH) shows wide variation among physicians." | 1.46 | Treatment Response and Outcome with Two Different Prednisolone Regimens in Autoimmune Hepatitis. ( Efe, C; Kav, T; Ozaslan, E; Purnak, T; Wahlin, S, 2017) |
| "High-quality data on the management of autoimmune hepatitis (AIH) are scarce." | 1.46 | Expert clinical management of autoimmune hepatitis in the real world. ( Andrade, RJ; Bouma, G; Dalekos, GN; de Boer, YS; Floreani, A; Gleeson, D; Heneghan, MA; Hirschfield, GM; Invernizzi, P; Lenzi, M; Liberal, R; Lohse, AW; Macedo, G; Milkiewicz, P; Terziroli, B; van Hoek, B; Vierling, JM, 2017) |
| "Adult studies of autoimmune hepatitis (AIH) have shown that the model of end-stage liver disease is associated with resistance to first-line treatment." | 1.46 | A national retrospective study of paediatric end-stage liver disease as a predictor of change to second-line therapy in children with autoimmune hepatitis. ( Ahmed, N; Alvarez, F; Critch, J; Jimenez-Rivera, C; Kamath, BM; Kim, J; Ling, SC; Schreiber, RA; Yap, J; Zizzo, AN, 2017) |
| "However, autoimmune hepatitis (AIH) in patients with HIV has rarely been reported." | 1.46 | Autoimmune hepatitis in patients with human immunodeficiency virus (HIV): Case reports of a rare, but important diagnosis with therapeutic implications. ( Beattie, A; Green, RM; Kia, L, 2017) |
| " The aim of the present study was to characterize the outcomes of pediatric patients with AIH and determine correlations between AZA dosing or 6-TGN metabolite levels and biochemical remission." | 1.46 | Outcomes in Pediatric Autoimmune Hepatitis and Significance of Azathioprine Metabolites. ( Capocelli, KE; Mack, CL; McCoy, AM; Pan, Z; Sheiko, MA; Sundaram, SS, 2017) |
| "Tacrolimus was started on 16/17 (94%) patients due to insufficient response to standard therapy." | 1.43 | Long-term follow-up of patients with difficult to treat type 1 autoimmune hepatitis on Tacrolimus therapy. ( Adams, DH; Füssel, K; Hirschfield, GM; Hodson, J; Lohse, AW; Mann, J; Oo, YH; Schramm, C; Than, NN; Weiler-Normann, C; Wiegard, C, 2016) |
| "Pregnancy with liver cirrhosis is a rare and dangerous event that exposes mother and fetus to potentially lethal risks." | 1.43 | Successful pregnancy with autoimmune cirrhosis. ( Braga, A; Braga, J, 2016) |
| "The prednisolone was used for remission induction in 37 patients; 86." | 1.43 | Autoimmune hepatitis and long-term disease course in children in Turkey, a single-center experience. ( Aydogdu, S; Ecevit, CO; Karakoyun, M; Kilicoglu, E; Ozgenc, F; Yagci, RV, 2016) |
| "The long-term outcomes of patients with autoimmune hepatitis (AIH) given the immunosuppressive treatment are considered to be preferable." | 1.43 | Autoimmune Hepatitis-related Cirrhosis: Clinical Features and Effectiveness of Immunosuppressive Treatment in Chinese Patients. ( Guo, LP; Li, SQ; Li, YN; Ma, H; Qian, YQ; Wang, BM; Zhang, J; Zhou, L, 2016) |
| "Therapy for autoimmune hepatitis has been prednisone based for decades; however, budesonide may be equally effective with fewer side effects." | 1.43 | Budesonide as first-line therapy for non-cirrhotic autoimmune hepatitis in children: a decision analysis. ( Mohammad, S, 2016) |
| "Retrospective review of AILD [autoimmune hepatitis type 1 and 2 (AIH1, AIH2), primary sclerosing cholangitis (PSC) and autoimmune sclerosing cholangitis (ASC)] seen at two pediatric liver units in Malaysia." | 1.42 | Characteristics and outcome of autoimmune liver disease in Asian children. ( Boey, CC; Chong, SY; Khoh, KM; Lee, WS; Lim, CB; Lum, SH; Ng, RT; Pailoor, J; Teo, KM, 2015) |
| "Treatment with everolimus induced a clear reduction of transaminases within 2 weeks." | 1.42 | Everolimus treatment for patients with autoimmune hepatitis and poor response to standard therapy and drug alternatives in use. ( Larsen, FS; Ytting, H, 2015) |
| "The patient was diagnosed to have autoimmune hepatitis type-1 and treated with injection methylprednisolone pulse (500 mg/day for 3 days) and maintained on oral steroids and azathioprine 100 mg." | 1.42 | A rare case of type-I auto-immune hepatitis and thyroiditis presenting with crescentic glomerulonephritis. ( Bhardwaj, M; Sunder, S; Venkataramanan, K; Verma, H, 2015) |
| "(1) Standard treatment of autoimmune hepatitis in adults should be steroid based." | 1.42 | Standard Treatment in Adults: Which Steroid? Or without Steroids? ( Gleeson, D, 2015) |
| "Giant cell hepatitis with autoimmune hemolytic anemia (GCH-AHA) is presumed to be an autoimmune disease, but the mechanism of liver injury is unknown." | 1.40 | Humoral immune mechanism of liver injury in giant cell hepatitis with autoimmune hemolytic anemia. ( Alvarez, F; Bass, LM; Melin-Aldana, H; Romero, R; Roy, CC; Vos, MB; Whitington, PF, 2014) |
| "Autoimmune hepatitis is a rare disease with high clinical variability." | 1.40 | Autoimmune hepatitis: trust in transaminases. ( Brissos, J; Cabral, J; Carrusca, C; Correia, M, 2014) |
| "Azathioprine (AZA) has been widely used in the therapy of inflammatory bowel disease (IBD) and autoimmune hepatitis (AIH)." | 1.40 | Differences in the adverse effects of azathioprine between inflammatory bowel disease and autoimmune hepatitis in Korean patients. ( Cho, KB; Choi, WY; Chung, WJ; Hwang, JS; Jang, BK; Kim, ES; Kim, YJ; Lee, YJ; Park, KS, 2014) |
| "Azathioprine is a widely used immunosuppressive drug." | 1.39 | Azathioprine-induced fever in autoimmune hepatitis. ( Chen, S; Khoury, T; Mizrahi, M; Ollech, JE; Shalit, M, 2013) |
| "Treatment with prednisone, azathioprine, and ursodeoxycholic acid led to a good response." | 1.39 | Type 2 autoimmune hepatitis overlapping with primary sclerosing cholangitis in a 10-year-old boy. ( Bahri, I; Boudawara, T; Gargouri, L; Maalej, B; Mahfoudh, A; Majdoub, I; Mnif, H; Mnif, L; Safi, F; Tahri, N; Turki, F, 2013) |
| "Current treatment strategies in autoimmune hepatitis (AIH) include long-term treatment with corticosteroids and/or azathioprine." | 1.39 | Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission. ( Beuers, U; Bouma, G; Brouwer, JT; Coenraad, MJ; de Man, RA; den Ouden, JW; Drenth, JP; Guichelaar, MM; Koek, GH; Mulder, CJ; van Buuren, HR; van Erpecum, KJ; van Gerven, NM; van Hoek, B; van Nieuwkerk, KM; Verdonk, RC; Verwer, BJ; Witte, BI, 2013) |
| "A 62-year-old woman with type 1 autoimmune hepatitis (AIH) failed to sustain remission when steroids were withdrawn from a regimen of steroids and azathioprine (AZA)." | 1.39 | Use of a xanthine oxidase inhibitor in autoimmune hepatitis. ( Al-Shamma, S; Eross, B; Mclaughlin, S, 2013) |
| "Ten percent of patients with autoimmune hepatitis (AIH) are nonresponsive or intolerant to thiopurine therapy." | 1.39 | Allopurinol safely and effectively optimises thiopurine metabolites in patients with autoimmune hepatitis. ( Bouma, G; de Boer, NK; de Boer, YS; Mulder, CJ; van Gerven, NM; van Nieuwkerk, CM, 2013) |
| "Autoimmune hepatitis is a relatively rare disease that may lead to rapidly progressing liver cirrhosis and even fulminant liver failure, if diagnosis and treatment is delayed or ineffective." | 1.38 | [Characteristics, diagnosis and therapy of patients with autoimmune hepatitis]. ( Larsen, FS; Ytting, H, 2012) |
| "The conventional treatment of autoimmune hepatitis (AIH) in children, which includes prednisone alone or in combination with azathioprine, induces remission in most cases but is often associated with poorly tolerated side effects." | 1.38 | Cyclosporine induced biochemical remission in childhood autoimmune hepatitis. ( Franulović, OZ; Kuna, AT; Lesar, T; Morić, BV; Rajacić, N, 2012) |
| "Reversibility of liver fibrosis with immunosuppressive therapy (IT) has been described in autoimmune hepatitis (AIH)." | 1.37 | [Histological regression of liver fibrosis with immunosuppressive therapy in autoimmune hepatitis]. ( Brahm, J; Márquez, S; Poniachik, J; Smok, G; Valera, JM, 2011) |
| "The pathogenesis of autoimmune hepatitis (AIH) is unclear, but viral infections have been proposed as a potential trigger in patients with genetic predisposition." | 1.37 | [A case of autoimmune hepatitis following acute hepatitis A]. ( Bae, WK; Kim, KA; Kim, NH; Kim, YD; Lee, JS; Rou, WS; Song, TJ, 2011) |
| "The prednisolone dose was tapered according to the decrease in the level of transaminases." | 1.37 | Ornidazole-induced autoimmune hepatitis. ( Akarca, US; Ersöz, G; Günşar, F; Karasu, Z; Tekın, F; Vardar, R; Yilmaz, F, 2011) |
| "Azathioprine was included in the treatment regimen in 74% of cases with doses generally <2 mg/kg." | 1.36 | Autoimmune hepatitis in a demographically isolated area of Australia. ( Haider, AS; Kaye, G; Thomson, A, 2010) |
| "Azathioprine dosage was significantly related to 6-TGN and 6-MeMPN levels (r = 0." | 1.36 | Monitoring of azathioprine metabolites in pediatric patients with autoimmune hepatitis. ( Boulieu, R; Daubard, M; Lachaux, A; Larger, M; Le Gall, C; Nguyen, TM, 2010) |
| "Treatment with prednisone and azathioprine resulted in a dramatically improved outcome." | 1.36 | De novo autoimmune hepatitis with centrilobular necrosis following liver transplantation for primary biliary cirrhosis: a case report. ( Wang, B; Wang, T; Zhang, Y, 2010) |
| "Azathioprine treatment is a long-term therapy and therefore it is at risk for non-adherence, which is considered an important determinant of treatment inefficacy." | 1.36 | Usefulness of the measurement of azathioprine metabolites in the assessment of non-adherence. ( Bartoli, F; Campanozzi, A; Decorti, G; Londero, M; Malusa, N; Marino, S; Martelossi, S; Stocco, G; Ventura, A, 2010) |
| "We describe the case of a girl with type 1 diabetes mellitus who developed icterus due to autoimmune hepatitis, a disease rarely found in children." | 1.36 | A girl with type 1 diabetes and a yellowish appearance. ( Hovinga, IC; Mearin, ML; Mul, D; Stam, ED, 2010) |
| "The role of the immune response in autoimmune hepatitis has not been studied before and after prednisone and azathioprine treatment." | 1.35 | Immune responses in autoimmune hepatitis: effect of prednisone and azathioprine treatment: case report. ( Bluth, MH; Chice, S; Durkin, HG; Kohlhoff, S; Norowitz, KB; Nowakowski, M; Silverberg, JI; Smith-Norowitz, TA, 2009) |
| "We describe a case of a young man with autoimmune hepatitis (AIH) following Epstein-Barr virus (EBV) infection, in whom a long follow-up showed favourable outcome with complete clinical recovery and failure to relapse after cessation of immunosuppressive therapy." | 1.35 | Autoimmune hepatitis following Epstein-Barr virus infection. ( Cabibi, D, 2008) |
| "Immunosuppressive treatment during pregnancy is sometimes necessary but the long- and short-term consequences are unrecognized." | 1.35 | [Autoimmune hepatitis and pregnancy: about a patient's three consecutive pregnancies]. ( Bolandard, F; Bonnin, M; Canis, M; Cotte, B; Houlle, C; Jardon, K; Mage, G; Nohuz, E; Rabischong, B; Rivoire, C, 2008) |
| "Following repeated liver biopsy, autoimmune hepatitis was assumed and prednisolone and azathioprine were initiated." | 1.35 | [Elevated liver enzymes in rheumatoid arthritis : differential diagnostic considerations based on a case report]. ( Hartmann, U; Reuss-Borst, M; Schmitt, S, 2008) |
| "Treatment with azathioprine and prednisone was started after diagnosis with an average time to remission of 14 months." | 1.34 | [Autoimmune hepatitis in pediatric patients]. ( Bernal Cuartas, C; García Romero, R; Martín de Carpi, J; Pinillos Pisón, S; Varea Calderón, V, 2007) |
| "Treatment with prednisone and azathioprine may lead to a rapid improvement in aminotransferase levels." | 1.34 | Development of autoimmune hepatitis in primary biliary cirrhosis. ( Gossard, AA; Lindor, KD, 2007) |
| "Autoimmune hepatitis has to be also looked for in the elderly with acute and chronic hepatitis." | 1.33 | Diagnosis and treatment of autoimmune hepatitis at age 65 and older. ( Buchel, E; Fevery, J; George, C; Nevens, F; van Steenbergen, W; Verslype, C, 2005) |
| "The usual onset of type 1 autoimmune hepatitis occurs at puberty or around menopause, whereas disease presentation in the advanced age is less often reported." | 1.33 | Clinical features of type 1 autoimmune hepatitis in elderly Italian patients. ( Bianchi, FB; Cassani, F; Ferri, S; Granito, A; Lenzi, M; Muratori, L; Muratori, P; Pappas, G, 2005) |
| "The need for immunosuppression in autoimmune hepatitis is established." | 1.33 | Early treatment response predicts the need for liver transplantation in autoimmune hepatitis. ( Adams, P; Ghent, C; Marotta, P; Tan, P, 2005) |
| " Records were reviewed for the dosage of immunosuppression, rate of relapse, steroid side effects, current status of liver function tests and evidence for cirrhosis and its complications." | 1.33 | Autoimmune hepatitis type 1: safety and efficacy of prolonged medical therapy. ( Boyer, JL; Seela, S; Sheela, H, 2005) |
| "In India, autoimmune hepatitis is uncommon and usually presents with chronic hepatitis or cirrhosis, acute hepatitis being less common." | 1.33 | Autoimmune hepatitis in India: profile of an uncommon disease. ( Alexander, G; Baba, CS; Choudhuri, G; Somani, SK, 2005) |
| "Azathioprine is a key drug in the management of autoimmune hepatitis (AIH), with effects mediated via conversion to 6-thioguanine (6-TG) and 6-methylmercaptopurine (6-MMP), the latter controlled by thiopurine methyltransferase (TPMT)." | 1.33 | Utility of thiopurine methyltransferase genotyping and phenotyping, and measurement of azathioprine metabolites in the management of patients with autoimmune hepatitis. ( Allan, ML; Bornstein, JD; Heneghan, MA; Muir, AJ; Tendler, DA, 2006) |
| "Azathioprine was introduced early following the diagnosis (range, 1-35 days)." | 1.33 | Azathioprine monotherapy for maintenance of remission in pediatric patients with autoimmune hepatitis. ( Banerjee, S; Bishop, WP; Rahhal, R, 2006) |
| "Although the prognosis of type 1 autoimmune hepatitis is generally good with immunosuppressive treatment, the disease progresses in some patients despite the treatment." | 1.33 | Persistent elevation of serum alanine aminotransferase levels leads to poor survival and hepatocellular carcinoma development in type 1 autoimmune hepatitis. ( Ikeda, H; Iwasaki, Y; Kobashi, H; Makino, Y; Miyake, Y; Okamaoto, R; Sakaguchi, K; Shiratori, Y; Takaguchi, K; Terada, R, 2006) |
| "Eighty-four patients with autoimmune hepatitis were consecutively recruited from 5 centers between January 1994 and March 2001." | 1.33 | Follow-up of children with autoimmune hepatitis treated with cyclosporine. ( Alvarez, F; Ciocca, M; Cuarterolo, M; Garsd, A; González, T; López, S; Ramonet, M; Velasco, CC, 2006) |
| "Life threatening cardiac arrhythmia was the first clinical manifestation of the disease." | 1.33 | [Overlap syndrome autoimmune hepatitis and primary biliary cirrhosis associated with antiphospholipid syndrome]. ( Laskowska, K; Majdan, M; Suszek, D; Targońska-Stepniak, B, 2006) |
| "Relapse of type 1 autoimmune hepatitis after drug withdrawal may relate to incomplete histological improvement during corticosteroid therapy and/or persistence of pathogenic mechanisms." | 1.32 | Histological features associated with relapse after corticosteroid withdrawal in type 1 autoimmune hepatitis. ( Carpenter, HA; Czaja, AJ, 2003) |
| "On liver biopsy, a diagnosis of type I autoimmune hepatitis with a possible autoimmune cholangitis overlap syndrome was made." | 1.32 | Autoimmune hepatitis, cryoglobulinaemia and untreated coeliac disease: a case report. ( Biecker, E; Reichen, J; Stieger, M; Zimmermann, A, 2003) |
| "Autoimmune hepatitis (AIH) and primary biliary cirrhosis (PBC) are two different liver diseases, however diagnosis criteria of these two affections can be found in a same patient." | 1.32 | [Primary biliary cirrhosis and autoimmune hepatitis overlap syndrome: therapeutic features in 5 patients]. ( Ben Ammar, A; Chaabouni, H; Cheikh, I; Ouerghi, H; Said, Y, 2003) |
| "Autoimmune hepatitis and primary biliary cirrhosis are two different liver diseases." | 1.32 | [The overlap syndrome of autoimmune hepatitis and primary biliary cirrhosis. Clinical and therapeutic analysis of 5 cases]. ( Ben Ammar, A; Chaabouni, H; Cheikh, I; Ouerghi, H; Said, Y, 2003) |
| "TPMT activity in patients with autoimmune hepatitis displays a similar distribution to that reported in other populations (approximately 1% of patients have low levels and 9% have intermediate levels) and it does not depend on the age, gender or simultaneous azathioprine treatment." | 1.32 | [Thiopurine methyltransferase activity in patients with autoimmune hepatitis]. ( Cara, C; Gisbert, JP; González-Guijarro, L; Moreno-Otero, R; Pajares, JM, 2003) |
| "The chronic hepatitis C-autoimmune hepatitis (AIH) overlap syndrome has been described in the literature, but to date appropriate therapy remains controversial." | 1.32 | Differential efficacy of corticosteroids and interferon in a patient with chronic hepatitis C-autoimmune hepatitis overlap syndrome. ( Dries, V; Goeser, T; Kasper, HU; Petersen-Benz, C, 2004) |
| " Complications of high AZA dosing make dose escalation potentially problematic." | 1.32 | Utility of azathioprine metabolite measurements in post-transplant recurrent autoimmune and immune-mediated hepatitis. ( Emre, SH; Rumbo, C; Shneider, BL, 2004) |
| "Azathioprine medication was stopped and the dermatologic features resolved completely after a period of 1 week." | 1.31 | [Erythema gyratum repens: drug reaction following azathioprine administration in a patient with type I autoimmune hepatitis]. ( Fölsch, UR; Günther, R; Hinrichsen, H; Nasser, S, 2002) |
| "The overlapping syndrome of systemic lupus erythematosus, autoimmune hepatitis, and autoimmune hyperlipidemia is discussed." | 1.31 | Autoimmune hyperlipidemia in a child with autoimmune hepatitis. ( Betzhold, J; Merati, S; Rumbo, C; Shneider, BL, 2002) |
| " AZA dosing was safely increased in patients with cirrhosis/hypersplenism." | 1.31 | Azathioprine metabolite measurements in the treatment of autoimmune hepatitis in pediatric patients: a preliminary report. ( Emerick, KM; Emre, S; Rumbo, C; Shneider, BL, 2002) |
| "Genetic susceptibility to type 1 autoimmune hepatitis is indicated by a preponderance of female subjects and strong associations with human leukocyte antigens (HLA) DRB1*0301 and DRB1*0401." | 1.31 | Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis. ( Agarwal, K; Czaja, AJ; Donaldson, PT; Jones, DE, 2000) |
| "Azathioprine was considered responsible for these two adverse reactions (shock) as an allergen." | 1.31 | [Autoimmune hepatitis complicated by intolerable pain of lower extremities and shock due to azathioprine]. ( Kawano, F; Kiyokawa, T; Sanada, I; Tsukamoto, A, 2000) |
| "Cases of so-called autoimmune hepatitis (AH) have been reported after liver transplantation." | 1.31 | Posttransplant immune hepatitis in pediatric liver transplant recipients: incidence and maintenance therapy with azathioprine. ( Andries, S; Bernard Otte, J; Burlet, M; Buts, JP; Casamayou, L; Reding, R; Sempoux, C; Sokal, E, 2001) |
| "Autoimmune hepatitis is one of the causes of chronic progressive liver disease in childhood." | 1.31 | Autoimmune hepatitis. ( Gürakan, F; Koçak, N; Ozen, H; Saltik, IN; Yüce, A, 2001) |
| "Most studies of autoimmune hepatitis consist of entirely white populations." | 1.31 | Autoimmune hepatitis in African Americans: presenting features and response to therapy. ( Boyer, TD; Bruno, CJ; Casanova, RL; Lim, KN, 2001) |
| "This study evaluated the effects of azathioprine in combination with low-dose prednisolone in the management of patients with intractable autoimmune hepatitis." | 1.31 | Therapeutic effects of azathioprine in combination with low-dose prednisolone in patients with intractable autoimmune hepatitis type 1. ( Fujiwara, A; Miyake, Y; Miyashita, M; Nishimura, M; Sakaguchi, K; Takenami, T; Terao, M; Tsuji, T, 2001) |
| "A 25-year-old Japanese woman with systemic lupus erythematosus (SLE) was admitted because of numbness of the face and left upper extremity, headache, and intermittent fever." | 1.31 | Systemic lupus erythematosus related transverse myelitis presenting longitudinal involvement of the spinal cord. ( Amano, H; Aramaki, T; Hirayama, Y; Kimura, KY; Seino, Y; Takano, T; Yamaguchi, H, 2002) |
| "There were 11 biopsy-proven recurrences (1 man, 10 women) of AIH after OLT." | 1.31 | Incidence and recurrence of autoimmune/alloimmune hepatitis in liver transplant recipients. ( Crippin, JS; Fasola, CG; Gogel, B; Goldstein, RM; Gonwa, TA; Hoover, TC; Jung, G; Klintmalm, GB; Levy, MF; Marubashi, S; Molmenti, EP; Molmenti, H; Murray, NG; Netto, GJ; Sanchez, EQ; Smith, DM, 2002) |
| "We also compare this atypical sclerosing cholangitis (group I) to typical sclerosing cholangitis (group II) and to autoimmune hepatitis with (group III) and without (group IV) cholestasis." | 1.30 | An atypical presentation for primary sclerosing cholangitis. ( Gomez, DA; Luketic, VA; Sanyal, AJ; Shiffman, ML, 1997) |
| "Our data show that symptoms of autoimmune hepatitis, which are responsive to the classical treatment for this condition, can appear in liver-transplant patients while they are on anti-rejection immunosuppression." | 1.30 | De-novo autoimmune hepatitis after liver transplantation. ( Davies, ET; Donaldson, PT; Hadzić, N; Heaton, ND; Kerkar, N; Mieli-Vergani, G; Portmann, B; Rela, M; Vergani, D, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (3.00) | 18.2507 |
| 2000's | 121 (36.34) | 29.6817 |
| 2010's | 160 (48.05) | 24.3611 |
| 2020's | 42 (12.61) | 2.80 |
| Authors | Studies |
|---|---|
| Kabaçam, G | 1 |
| Wahlin, S | 3 |
| Efe, C | 4 |
| Rahim, MN | 1 |
| Heneghan, MA | 10 |
| Kemme, S | 1 |
| Mack, CL | 3 |
| Sirbe, C | 1 |
| Simu, G | 1 |
| Szabo, I | 1 |
| Grama, A | 1 |
| Pop, TL | 1 |
| Dalekos, GN | 6 |
| Arvaniti, P | 3 |
| Gatselis, NK | 3 |
| Samakidou, A | 2 |
| Gabeta, S | 2 |
| Rigopoulou, E | 1 |
| Koukoulis, GK | 4 |
| Zachou, K | 3 |
| Vogelbacher, L | 1 |
| Thimme, R | 1 |
| Böttler, T | 1 |
| Harrington, C | 1 |
| Krishnan, S | 1 |
| Cravedi, P | 1 |
| Assis, DN | 1 |
| Levitsky, J | 1 |
| Olivas, I | 1 |
| Rodríguez-Tajes, S | 1 |
| Londoño, MC | 2 |
| Lyberopoulou, A | 1 |
| Banakou, E | 1 |
| Hong, X | 1 |
| Hu, S | 1 |
| Zhang, P | 1 |
| Gao, X | 1 |
| Qiao, Z | 1 |
| Xia, C | 1 |
| Xu, Y | 1 |
| Jin, X | 1 |
| Xiang, X | 1 |
| Chen, H | 1 |
| Jagtap, AB | 1 |
| S, C | 1 |
| Chaitanya, V | 1 |
| Lall, B | 1 |
| Porwal, YC | 1 |
| Takakusagi, S | 3 |
| Takagi, H | 3 |
| Yamazaki, Y | 3 |
| Kosone, T | 3 |
| Nagashima, S | 3 |
| Takahashi, M | 3 |
| Murata, K | 3 |
| Okamoto, H | 3 |
| Snijders, RJALM | 3 |
| Stoelinga, AEC | 2 |
| Gevers, TJG | 5 |
| Pape, S | 7 |
| Biewenga, M | 2 |
| Verdonk, RC | 3 |
| de Jonge, HJM | 2 |
| Vrolijk, JM | 5 |
| Bakker, SF | 2 |
| Vanwolleghem, T | 2 |
| de Boer, YS | 5 |
| Pronk, MAMCB | 2 |
| Beuers, UHW | 2 |
| van der Meer, AJ | 2 |
| van Gerven, NMF | 2 |
| Sijtsma, MGM | 2 |
| Verwer, BJ | 5 |
| Gisbertz, IAM | 2 |
| Bartelink, M | 2 |
| van den Brand, FF | 3 |
| Sebib Korkmaz, K | 2 |
| van den Berg, AP | 3 |
| Guichelaar, MMJ | 2 |
| Soufidi, K | 2 |
| Levens, AD | 2 |
| van Hoek, B | 6 |
| Drenth, JPH | 7 |
| Maggiore, G | 4 |
| Bernard, O | 1 |
| Mosca, A | 1 |
| Ballot, E | 2 |
| Johanet, C | 2 |
| Jacquemin, E | 1 |
| Kim, JK | 1 |
| Steinmann, S | 1 |
| Lohse, AW | 13 |
| Ueno, M | 1 |
| Takabatake, H | 1 |
| Itakura, J | 1 |
| Fujita, R | 1 |
| Kayahara, T | 1 |
| Morimoto, Y | 1 |
| Notohara, K | 1 |
| Mizuno, M | 1 |
| Harrison, L | 2 |
| Hoeroldt, B | 1 |
| Dhaliwal, H | 1 |
| Wadland, E | 1 |
| Dube, A | 1 |
| Gleeson, D | 8 |
| Ludz, C | 1 |
| Stirnimann, G | 1 |
| Semela, D | 1 |
| Mertens, J | 1 |
| Kremer, AE | 1 |
| Filipowicz Sinnreich, M | 1 |
| Sokollik, C | 2 |
| Bernsmeier, C | 1 |
| Bresson-Hadni, S | 1 |
| McLin, V | 1 |
| Rock, N | 1 |
| Braegger, C | 1 |
| Posovszky, C | 1 |
| Müller, P | 1 |
| Cremer, M | 1 |
| De Gottardi, A | 1 |
| Galante, A | 1 |
| Furlano, R | 1 |
| Righini-Grunder, F | 1 |
| Becker, B | 1 |
| Böhm, S | 1 |
| Heyland, K | 1 |
| Nydegger, A | 1 |
| Limoni, C | 1 |
| Vergani, D | 10 |
| Mieli-Vergani, G | 9 |
| Di Bartolomeo, C | 1 |
| Cerny, A | 1 |
| Terziroli Beretta-Piccoli, B | 3 |
| Goel, A | 2 |
| Kwo, P | 1 |
| Yik, B | 1 |
| Shah, N | 1 |
| Binicier, OB | 1 |
| Günay, S | 1 |
| Nevens, F | 3 |
| Verslype, C | 2 |
| Mertens, C | 1 |
| Tjwa, ETTL | 1 |
| Schramm, C | 9 |
| Gevers, TJ | 1 |
| Yassin, S | 1 |
| De Lacy, R | 1 |
| Pillay, K | 1 |
| Goddard, E | 1 |
| Tanaka, A | 2 |
| Czaja, AJ | 21 |
| Bouma, G | 9 |
| van Nieuwkerk, CMJ | 3 |
| Taubert, R | 5 |
| Jaeckel, E | 5 |
| Manns, MP | 8 |
| Papp, M | 2 |
| Sipeki, N | 1 |
| Stickel, F | 2 |
| Ozaslan, E | 3 |
| Purnak, T | 3 |
| Kessener, DJN | 1 |
| Kahraman, A | 1 |
| Wedemeyer, H | 1 |
| Hartl, J | 3 |
| McNally, BB | 1 |
| Carey, EJ | 1 |
| Cuarterolo, ML | 2 |
| Ciocca, M | 4 |
| López, S | 2 |
| Araujo, M | 1 |
| Álvarez, F | 6 |
| Crouwel, F | 1 |
| Buiter, HJC | 1 |
| de Boer, NK | 5 |
| Liberal, R | 3 |
| Gaspar, R | 1 |
| Lopes, S | 1 |
| Macedo, G | 2 |
| Galaski, J | 1 |
| Koop, AC | 1 |
| Lütgehetmann, M | 1 |
| Weiler-Normann, C | 4 |
| Kastin, D | 1 |
| Siegel, M | 1 |
| Anderson, R | 2 |
| Aronsohn, A | 1 |
| Aksoy, B | 1 |
| Baran, M | 1 |
| Cagan Appak, Y | 1 |
| Sag, E | 1 |
| Cakir, M | 1 |
| Guven, B | 1 |
| Yavuz, S | 1 |
| Emir, B | 1 |
| Tumgor, G | 1 |
| Komori, A | 2 |
| Bolia, R | 3 |
| Srivastava, A | 3 |
| Afaa, TJ | 1 |
| Amegan-Aho, KH | 1 |
| Dono, MT | 1 |
| Odei, E | 1 |
| Awuku, YA | 1 |
| Miura, R | 1 |
| Yagi, M | 1 |
| Matsumoto, K | 1 |
| Miki, A | 1 |
| Isono, A | 1 |
| Aoyagi, H | 1 |
| Abe, K | 1 |
| Tachizawa, N | 1 |
| Arizumi, T | 1 |
| Aiso, M | 1 |
| Kodashima, S | 1 |
| Asaoka, Y | 1 |
| Yamamoto, T | 1 |
| Miao, Q | 2 |
| Yan, L | 1 |
| Zhou, Y | 1 |
| Li, Y | 1 |
| Zou, Y | 1 |
| Wang, L | 1 |
| Bai, Y | 1 |
| Zhang, J | 2 |
| Stolk, MFJ | 1 |
| van Erpecum, KJ | 2 |
| Vuille-Lessard, É | 1 |
| Montani, M | 1 |
| Bosch, J | 1 |
| Semmo, N | 1 |
| Eriksen, PL | 1 |
| Kreutzfeldt, M | 1 |
| Grønbaek, H | 1 |
| Thorsen, K | 1 |
| Vang, S | 1 |
| Jessen, N | 1 |
| Vilstrup, H | 1 |
| Muratori, P | 8 |
| Lenzi, M | 6 |
| Migliori, M | 1 |
| Muratori, L | 7 |
| Sebode, M | 2 |
| Jo, W | 1 |
| Suh, YS | 1 |
| Lee, SI | 1 |
| Cheon, YH | 1 |
| Hong, J | 1 |
| Lee, SS | 2 |
| Kim, JE | 1 |
| Ko, GH | 1 |
| Kim, HO | 1 |
| Caballero-Mateos, AM | 1 |
| López Garrido, MÁ | 1 |
| Becerra Massare, P | 1 |
| de Teresa Galván, J | 1 |
| Kerkar, N | 4 |
| Zizzo, AN | 2 |
| Valentino, PL | 1 |
| Shah, PS | 1 |
| Kamath, BM | 2 |
| Kotha, S | 1 |
| Tritto, G | 1 |
| Wong, T | 1 |
| Berry, P | 1 |
| Nishizawa, A | 1 |
| Ishikawa, T | 1 |
| Hirose, M | 1 |
| Satoh, H | 1 |
| Nishii, S | 1 |
| Tomita, K | 1 |
| Hokari, R | 1 |
| Satoh, T | 1 |
| Kim, BH | 2 |
| Choi, HY | 1 |
| Ki, M | 1 |
| Kim, KA | 3 |
| Jang, ES | 1 |
| Jeong, SH | 2 |
| Yang, X | 1 |
| Xu, H | 1 |
| Yang, J | 1 |
| Yang, L | 1 |
| Kav, T | 1 |
| Palamuthusingam, D | 1 |
| Mantha, M | 1 |
| Dheda, S | 1 |
| Nastasio, S | 3 |
| Sciveres, M | 3 |
| Abdel-Razik, A | 1 |
| Mousa, N | 1 |
| Zakaria, S | 1 |
| Elhelaly, R | 1 |
| Elzehery, R | 1 |
| Zalata, K | 1 |
| Awad, M | 1 |
| Eldeeb, AA | 1 |
| Abdelsalam, M | 1 |
| Kushner, T | 1 |
| Shinkai, K | 1 |
| Fox, L | 1 |
| Ying, D | 1 |
| Gross, A | 1 |
| Balitzer, D | 1 |
| Gill, R | 1 |
| Brandman, D | 1 |
| Munz, M | 1 |
| Pretscher, D | 1 |
| Wilhelm, M | 1 |
| Holzgrabe, U | 1 |
| Sörgel, F | 1 |
| Birkmann, J | 1 |
| Yan, X | 1 |
| Jin, J | 1 |
| Carbone, M | 1 |
| Stangos, G | 1 |
| Perini, L | 1 |
| Lalanne, C | 2 |
| Ronca, V | 1 |
| Cazzagon, N | 1 |
| Bianchi, G | 2 |
| Floreani, A | 2 |
| Invernizzi, P | 3 |
| Jones, D | 1 |
| Terracciano, L | 1 |
| Torbenson, M | 1 |
| Vierling, JM | 3 |
| Schmeltzer, PA | 1 |
| Russo, MW | 1 |
| Rizvi, S | 1 |
| Gawrieh, S | 2 |
| de Boer, NKH | 1 |
| Mulder, CJJ | 1 |
| Bloemena, E | 2 |
| Bakker, CM | 1 |
| Tan, ACITL | 1 |
| Ter Borg, F | 1 |
| Ter Borg, MJ | 1 |
| van den Hazel, SJ | 1 |
| Inderson, A | 1 |
| Tushuizen, ME | 1 |
| Rajanayagam, J | 1 |
| Hardikar, W | 1 |
| Aljumah, AA | 1 |
| Al Jarallah, B | 1 |
| Albenmousa, A | 1 |
| Al Khathlan, A | 1 |
| Al Zanbagi, A | 1 |
| Al Quaiz, M | 1 |
| Al-Judaibi, B | 1 |
| Nabrawi, K | 1 |
| Al Hamoudi, W | 1 |
| Alghamdi, M | 1 |
| Fallatah, H | 1 |
| McLin, VA | 1 |
| Giannakopoulos, G | 1 |
| Verbaan, H | 2 |
| Friis-Liby, IL | 1 |
| Sangfelt, P | 1 |
| Nyhlin, N | 1 |
| Almer, S | 1 |
| Hupa-Breier, KL | 1 |
| López Couceiro, L | 1 |
| Gómez Domínguez, E | 1 |
| Muñoz Gómez, R | 1 |
| Castellano Tortajada, G | 1 |
| Ibarrola de Andrés, C | 1 |
| Fernández Vázquez, I | 1 |
| Trivedi, PJ | 1 |
| Hubscher, SG | 2 |
| Heneghan, M | 1 |
| Hirschfield, GM | 4 |
| Matarazzo, L | 1 |
| Malaventura, C | 1 |
| Cirillo, F | 1 |
| Riva, S | 1 |
| Rigopoulou, EI | 2 |
| Gyftaki, S | 1 |
| Tsimourtou, V | 1 |
| Hadjigeorgiou, G | 1 |
| Llovet, LP | 1 |
| Horta, D | 1 |
| Eliz, MG | 1 |
| Berenguer, M | 1 |
| Fábrega, E | 1 |
| Sáez-Royuela, F | 1 |
| García-Retortillo, M | 1 |
| Torrijos, YS | 1 |
| Romero-Gómez, M | 1 |
| Fernández, C | 1 |
| Domínguez, EG | 1 |
| Parés, A | 1 |
| Belias, M | 1 |
| Mustafajev, IF | 1 |
| Doycheva, I | 1 |
| Watt, KD | 1 |
| Gulamhusein, AF | 1 |
| Wehrman, A | 1 |
| Waisbourd-Zinman, O | 1 |
| Shah, A | 1 |
| Hilmara, D | 1 |
| Lin, H | 1 |
| Rand, EB | 1 |
| Santiago, P | 1 |
| Schwartz, I | 1 |
| Tamariz, L | 1 |
| Levy, C | 1 |
| Silva, J | 1 |
| Brito, BS | 1 |
| Silva, INN | 1 |
| Nóbrega, VG | 1 |
| da Silva, MCSM | 1 |
| Gomes, HDN | 1 |
| Fortes, FM | 1 |
| Pimentel, AM | 1 |
| Mota, J | 1 |
| Almeida, N | 1 |
| Surlo, VC | 1 |
| Lyra, A | 1 |
| Rocha, R | 1 |
| Santana, GO | 1 |
| Di Giorgio, A | 2 |
| D'Adda, A | 1 |
| Marseglia, A | 1 |
| Sonzogni, A | 3 |
| Licini, L | 1 |
| Nicastro, E | 1 |
| D'Antiga, L | 2 |
| Kawaguchi, T | 1 |
| Arinaga-Hino, T | 1 |
| Shimizu, M | 1 |
| Tanikawa, K | 1 |
| Tokushige, T | 1 |
| Hirai, S | 1 |
| Nagamatsu, H | 1 |
| Tateishi, H | 1 |
| Takata, A | 1 |
| Ide, T | 2 |
| Torimura, T | 2 |
| Yu, ZJ | 1 |
| Zhang, LL | 1 |
| Huang, TT | 1 |
| Zhu, JS | 1 |
| He, ZB | 1 |
| Yeend-Curd-Trimble, H | 1 |
| Kelly, K | 1 |
| Ghosh, I | 1 |
| MacDonald, D | 1 |
| Durazzo, M | 1 |
| Lupi, G | 1 |
| Scandella, M | 1 |
| Ferro, A | 1 |
| Gruden, G | 1 |
| Peng, H | 1 |
| Lim, T | 1 |
| Nam, J | 1 |
| Lee, J | 1 |
| Méndez-Flores, S | 1 |
| Charli-Joseph, Y | 1 |
| Saeb-Lima, M | 1 |
| Orozco-Topete, R | 1 |
| Fernández Sánchez, M | 1 |
| Zhao, XY | 1 |
| Rakhda, MI | 1 |
| Wang, TI | 1 |
| Jia, JD | 1 |
| Burak, KW | 1 |
| Swain, MG | 1 |
| Santodomingo-Garzon, T | 1 |
| Santodomino-Garzon, T | 1 |
| Urbanski, SJ | 1 |
| Aspinall, AI | 1 |
| Coffin, CS | 1 |
| Myers, RP | 1 |
| Woynarowski, M | 1 |
| Nemeth, A | 1 |
| Baruch, Y | 1 |
| Koletzko, S | 1 |
| Melter, M | 1 |
| Rodeck, B | 1 |
| Strassburg, CP | 4 |
| Pröls, M | 1 |
| Woźniak, M | 1 |
| Delgado, JS | 1 |
| Vodonos, A | 1 |
| Malnick, S | 2 |
| Kriger, O | 1 |
| Wilkof-Segev, R | 1 |
| Delgado, B | 1 |
| Novack, V | 1 |
| Rosenthal, A | 1 |
| Menachem, Y | 1 |
| Melzer, E | 2 |
| Fich, A | 1 |
| Khoury, T | 1 |
| Ollech, JE | 1 |
| Chen, S | 1 |
| Mizrahi, M | 1 |
| Shalit, M | 1 |
| Whitington, PF | 1 |
| Vos, MB | 1 |
| Bass, LM | 1 |
| Melin-Aldana, H | 1 |
| Romero, R | 1 |
| Roy, CC | 1 |
| Granito, A | 3 |
| Gatselis, N | 1 |
| Fabbri, A | 1 |
| Oh, HJ | 1 |
| Mok, YM | 1 |
| Baek, MS | 1 |
| Lee, JK | 1 |
| Seo, BS | 1 |
| Kim, TH | 1 |
| Choi, KH | 1 |
| Hwang, IK | 1 |
| Ra, JE | 1 |
| Oh, YR | 1 |
| Kim, YS | 2 |
| Cho, EY | 2 |
| Kim, HC | 1 |
| Sohn, YW | 1 |
| Gargouri, L | 1 |
| Mnif, L | 1 |
| Safi, F | 1 |
| Turki, F | 1 |
| Majdoub, I | 1 |
| Maalej, B | 1 |
| Bahri, I | 1 |
| Mnif, H | 1 |
| Boudawara, T | 1 |
| Tahri, N | 1 |
| Mahfoudh, A | 1 |
| Rosen, D | 1 |
| Chu, J | 1 |
| Morotti, R | 1 |
| Levanon, D | 1 |
| Rose, S | 1 |
| Lee, S | 1 |
| Arnon, R | 1 |
| Zhang, Y | 2 |
| Sun, WL | 1 |
| Jin, DL | 1 |
| Jing-Hua, D | 1 |
| Vallejo Senra, N | 1 |
| Fernández Castroagudín, J | 1 |
| Molina Pérez, E | 1 |
| Domínguez-Muñoz, JE | 1 |
| Brissos, J | 1 |
| Carrusca, C | 1 |
| Correia, M | 1 |
| Cabral, J | 1 |
| Charlagorla, P | 1 |
| Sublett, S | 1 |
| Sy, F | 1 |
| Kessler, E | 1 |
| Gad, A | 1 |
| Yang, S | 1 |
| McHargue, C | 1 |
| Chatrath, H | 1 |
| Allen, L | 1 |
| Boyer, TD | 2 |
| Lazarescu, RE | 1 |
| Vinelli, M | 1 |
| Bravi, M | 1 |
| Bonanomi, E | 1 |
| Alessio, G | 1 |
| Zen, Y | 1 |
| Colledan, M | 1 |
| Lee, YJ | 2 |
| Choi, WY | 1 |
| Park, KS | 1 |
| Kim, YJ | 2 |
| Cho, KB | 1 |
| Kim, ES | 1 |
| Jang, BK | 1 |
| Chung, WJ | 1 |
| Hwang, JS | 2 |
| Zold, E | 1 |
| Bodolay, E | 1 |
| Dezső, B | 1 |
| Soos, G | 1 |
| Nakken, B | 1 |
| Szodoray, P | 1 |
| Chua, EW | 1 |
| Cree, S | 1 |
| Barclay, ML | 1 |
| Doudney, K | 1 |
| Lehnert, K | 1 |
| Aitchison, A | 1 |
| Kennedy, MA | 1 |
| Lee, WS | 1 |
| Lum, SH | 1 |
| Lim, CB | 1 |
| Chong, SY | 1 |
| Khoh, KM | 1 |
| Ng, RT | 1 |
| Teo, KM | 1 |
| Boey, CC | 1 |
| Pailoor, J | 1 |
| Ytting, H | 2 |
| Larsen, FS | 2 |
| Corrigan, M | 1 |
| Oo, YH | 2 |
| Adams, DH | 2 |
| Dhaliwal, HK | 2 |
| Hoeroldt, BS | 1 |
| Dube, AK | 1 |
| McFarlane, E | 2 |
| Underwood, JC | 1 |
| Karajeh, MA | 1 |
| Zhu, JY | 1 |
| Han, Y | 2 |
| Sunder, S | 1 |
| Venkataramanan, K | 1 |
| Verma, H | 1 |
| Bhardwaj, M | 1 |
| Salvado, M | 1 |
| Vargas, V | 1 |
| Vidal, M | 1 |
| Simon-Talero, M | 1 |
| Camacho, J | 1 |
| Gamez, J | 1 |
| Than, NN | 1 |
| Wiegard, C | 3 |
| Füssel, K | 1 |
| Mann, J | 1 |
| Hodson, J | 1 |
| Jiménez-Rivera, C | 2 |
| Ling, SC | 2 |
| Ahmed, N | 2 |
| Yap, J | 2 |
| Aglipay, M | 1 |
| Barrowman, N | 1 |
| Graitson, S | 1 |
| Critch, J | 2 |
| Rashid, M | 1 |
| Ng, VL | 1 |
| Roberts, EA | 1 |
| Brill, H | 1 |
| Dowhaniuk, JK | 1 |
| Bruce, G | 1 |
| Bax, K | 1 |
| Deneau, M | 1 |
| Guttman, OR | 1 |
| Schreiber, RA | 2 |
| Martin, S | 1 |
| van Nieuwkerk, CM | 3 |
| Lammert, C | 1 |
| Loy, VM | 1 |
| Oshima, K | 1 |
| Rodrigues, AT | 1 |
| Liu, PM | 1 |
| Fagundes, ED | 1 |
| Queiroz, TC | 1 |
| de Souza Haueisen Barbosa, P | 1 |
| Silva, SL | 1 |
| Simões E Silva, AC | 1 |
| Miranda, DM | 1 |
| Ferreira, AR | 1 |
| Alberti, LR | 1 |
| Braga, A | 1 |
| Braga, J | 1 |
| Meijer, B | 1 |
| Sarda, G | 1 |
| Harvey, R | 1 |
| Soares, JC | 1 |
| Borgonovo, A | 1 |
| Maggi, DC | 1 |
| Pasinato, AP | 1 |
| Ramos, FG | 1 |
| Dantas-Corrêa, EB | 1 |
| Schiavon, LL | 1 |
| Narciso-Schiavon, JL | 1 |
| Park, SW | 1 |
| Um, SH | 2 |
| Lee, HA | 1 |
| Kim, SH | 1 |
| Sim, Y | 1 |
| Yim, SY | 1 |
| Seo, YS | 2 |
| Ryu, HS | 1 |
| Karakoyun, M | 1 |
| Ecevit, CO | 1 |
| Kilicoglu, E | 1 |
| Aydogdu, S | 1 |
| Yagci, RV | 1 |
| Ozgenc, F | 1 |
| Sayin, R | 1 |
| Gokgul, A | 1 |
| Ebinc, S | 1 |
| Dulger, AC | 1 |
| Tombul, T | 1 |
| Ardalan, ZS | 1 |
| Vasudevan, A | 1 |
| Testro, AG | 1 |
| Krawitt, EL | 3 |
| Brinkert, F | 1 |
| Arrenberg, P | 1 |
| Krech, T | 1 |
| Grabhorn, E | 1 |
| Lohse, A | 1 |
| Al Taii, H | 1 |
| Hanouneh, MA | 1 |
| Hanouneh, I | 1 |
| Lopez, R | 1 |
| Zein, N | 1 |
| Alkhouri, N | 1 |
| Li, YN | 1 |
| Ma, H | 1 |
| Zhou, L | 1 |
| Guo, LP | 1 |
| Li, SQ | 1 |
| Qian, YQ | 1 |
| Wang, BM | 1 |
| Chi, XL | 1 |
| Xiao, HM | 1 |
| Xie, YB | 1 |
| Cai, GS | 1 |
| Jiang, JM | 1 |
| Tian, GJ | 1 |
| Shi, MJ | 1 |
| Wu, SD | 1 |
| Zhao, PT | 1 |
| Chen, HJ | 1 |
| Andrade, RJ | 1 |
| Milkiewicz, P | 2 |
| Terziroli, B | 1 |
| Kim, J | 1 |
| Kia, L | 1 |
| Beattie, A | 1 |
| Green, RM | 1 |
| Sheiko, MA | 1 |
| Sundaram, SS | 1 |
| Capocelli, KE | 1 |
| Pan, Z | 1 |
| McCoy, AM | 1 |
| Keskin, M | 1 |
| Savaş-Erdeve, Ş | 1 |
| Özbay-Hoşnut, F | 1 |
| Kurnaz, E | 1 |
| Çetinkaya, S | 1 |
| Aycan, Z | 1 |
| Cropley, A | 1 |
| Weltman, M | 1 |
| O'Brien, C | 1 |
| Joshi, S | 1 |
| Feld, JJ | 1 |
| Guindi, M | 1 |
| Dienes, HP | 1 |
| Heathcote, EJ | 1 |
| Miyake, Y | 3 |
| Yamamoto, K | 1 |
| Terrabuio, DR | 1 |
| Abrantes-Lemos, CP | 1 |
| Carrilho, FJ | 1 |
| Cançado, EL | 1 |
| Alvarez Beltran, M | 1 |
| Infante Pina, D | 1 |
| Tormo Carnicé, R | 1 |
| Segarra Cantón, O | 1 |
| Redecillas Ferreiro, S | 1 |
| Katherine Martin, L | 1 |
| Porcu, P | 1 |
| Baiocchi, RA | 1 |
| Erter, JW | 1 |
| Chaudhury, AR | 1 |
| Maggs, J | 1 |
| Cullen, S | 1 |
| Martínez-Odriozola, P | 1 |
| Gutiérrez-Macías, A | 1 |
| Ibarmia-Lahuerta, J | 1 |
| Muñóz-Sánchez, J | 1 |
| Stiefelhagen, P | 1 |
| Krok, KL | 1 |
| Munoz, SJ | 1 |
| Bluth, MH | 1 |
| Kohlhoff, S | 1 |
| Norowitz, KB | 1 |
| Silverberg, JI | 1 |
| Chice, S | 1 |
| Nowakowski, M | 1 |
| Durkin, HG | 1 |
| Smith-Norowitz, TA | 1 |
| Haider, AS | 1 |
| Kaye, G | 1 |
| Thomson, A | 1 |
| Schreuder, TC | 1 |
| Mulder, CJ | 5 |
| van Nieuwkerk, KM | 2 |
| Hindorf, U | 1 |
| Jahed, K | 1 |
| Bergquist, A | 1 |
| Prytz, H | 1 |
| Wallerstedt, S | 1 |
| Werner, M | 1 |
| Olsson, R | 1 |
| Björnsson, E | 1 |
| Peterson, C | 1 |
| Almer, SH | 1 |
| Dumortier, J | 1 |
| Arita, CT | 1 |
| Rivet, C | 1 |
| LeGall, C | 1 |
| Bouvier, R | 1 |
| Fabien, N | 1 |
| Guillaud, O | 1 |
| Collardeau-Frachon, S | 1 |
| Scoazec, JY | 1 |
| Lachaux, A | 2 |
| Kil, JS | 1 |
| Lee, JH | 1 |
| Han, AR | 1 |
| Kang, JY | 1 |
| Won, HJ | 1 |
| Jung, HY | 1 |
| Lim, HM | 1 |
| Gwak, GY | 1 |
| Choi, MS | 1 |
| Koh, KC | 1 |
| Paik, SW | 1 |
| Yoo, BC | 1 |
| Lamers, MM | 1 |
| van Oijen, MG | 1 |
| Pronk, M | 1 |
| Drenth, JP | 2 |
| Nguyen, TM | 1 |
| Daubard, M | 1 |
| Le Gall, C | 1 |
| Larger, M | 1 |
| Boulieu, R | 1 |
| Adams, B | 1 |
| Lazarchick, J | 1 |
| Medina, AM | 1 |
| Willner, IR | 1 |
| Neville, B | 1 |
| Murphy, E | 1 |
| Stuart, R | 1 |
| Costa, LJ | 1 |
| Hellweg, S | 1 |
| Müller, S | 1 |
| Moreno-Otero, R | 2 |
| Trapero-Marugán, M | 1 |
| García-Buey, L | 1 |
| García-Sancchez, A | 1 |
| Wang, B | 1 |
| Wang, T | 1 |
| Stocco, G | 1 |
| Londero, M | 1 |
| Campanozzi, A | 1 |
| Martelossi, S | 1 |
| Marino, S | 1 |
| Malusa, N | 1 |
| Bartoli, F | 1 |
| Decorti, G | 1 |
| Ventura, A | 1 |
| Gil, H | 1 |
| Valera, JM | 1 |
| Smok, G | 1 |
| Márquez, S | 1 |
| Poniachik, J | 1 |
| Brahm, J | 1 |
| Ferucci, ED | 1 |
| Hurlburt, KJ | 1 |
| Mayo, MJ | 2 |
| Livingston, S | 1 |
| Deubner, H | 1 |
| Gove, J | 1 |
| Plotnik, J | 1 |
| McMahon, BJ | 1 |
| Ozbalkan, Z | 1 |
| Karaaslan, Y | 1 |
| Altiparmak, E | 1 |
| Venkatesh, PG | 1 |
| Navaneethan, U | 1 |
| Kim, YD | 1 |
| Rou, WS | 1 |
| Lee, JS | 1 |
| Song, TJ | 1 |
| Bae, WK | 1 |
| Kim, NH | 1 |
| López, SI | 1 |
| Oleastro, M | 1 |
| Rocca, A | 1 |
| de Dávila, MT | 2 |
| Roy, A | 1 |
| Fernández, MC | 1 |
| Nievas, E | 1 |
| Bosaleh, A | 1 |
| Torgerson, TR | 1 |
| Ruiz, JA | 1 |
| Cabibi, D | 1 |
| Montano-Loza, AJ | 1 |
| Shums, Z | 3 |
| Norman, GL | 3 |
| Fallatah, HI | 1 |
| Akbar, HO | 1 |
| Snider, KR | 1 |
| Potter, TG | 1 |
| Savoia, F | 2 |
| Casadio, C | 1 |
| Tabanelli, M | 2 |
| Gaddoni, G | 1 |
| Patrizi, A | 1 |
| Spadola, G | 2 |
| Lanzanova, G | 1 |
| Zago, S | 1 |
| Maio, V | 1 |
| Giacomoni, P | 1 |
| Hino-Arinaga, T | 1 |
| Kuromatsu, R | 1 |
| Miyajima, I | 1 |
| Ogata, K | 1 |
| Kuwahara, R | 1 |
| Hisamochi, A | 1 |
| Sata, M | 1 |
| Ersöz, G | 1 |
| Vardar, R | 1 |
| Akarca, US | 1 |
| Tekın, F | 1 |
| Yilmaz, F | 1 |
| Günşar, F | 1 |
| Karasu, Z | 1 |
| Vafa, H | 1 |
| Demetter, P | 1 |
| Goyens, P | 1 |
| De Laet, C | 1 |
| Adler, M | 1 |
| Chin, LK | 1 |
| Cheah, CY | 1 |
| Michael, PM | 1 |
| MacKinnon, RN | 1 |
| Campbell, LJ | 1 |
| Thornhill, EL | 1 |
| Schneider, S | 1 |
| Lennard, L | 1 |
| Vajro, P | 1 |
| Paolella, G | 1 |
| Vitfell-Pedersen, J | 1 |
| Jørgensen, MH | 1 |
| Müller, K | 1 |
| Heilmann, C | 1 |
| Cicalese, MP | 1 |
| Iorio, R | 2 |
| Duek, G | 1 |
| Basevitz, A | 1 |
| Hovinga, IC | 1 |
| Stam, ED | 1 |
| Mearin, ML | 1 |
| Mul, D | 1 |
| Alessio, MG | 1 |
| Smyk, DS | 1 |
| Lleo, A | 1 |
| Fabris, L | 1 |
| Candusso, M | 1 |
| Bogdanos, DP | 1 |
| Torre, G | 1 |
| van Gerven, NM | 2 |
| Witte, BI | 1 |
| Coenraad, MJ | 1 |
| Beuers, U | 1 |
| van Buuren, HR | 1 |
| de Man, RA | 1 |
| den Ouden, JW | 1 |
| Koek, GH | 1 |
| Brouwer, JT | 1 |
| Guichelaar, MM | 1 |
| Tak, WY | 1 |
| Ahn, SH | 1 |
| Jung, EU | 1 |
| Lee, JI | 1 |
| Yeon, JE | 1 |
| Song, BC | 1 |
| Kim, JH | 1 |
| Jung, YK | 1 |
| Park, CK | 1 |
| Min, HJ | 1 |
| Lee, ES | 1 |
| Kwon, SY | 1 |
| Chae, HB | 1 |
| Kim, DJ | 1 |
| Shin, SR | 1 |
| Moseley, RH | 1 |
| Manoogian, B | 1 |
| Shehab, T | 1 |
| Saint, S | 1 |
| Serghini, M | 1 |
| Haddad, W | 1 |
| Karoui, S | 1 |
| Ben Mustapha, N | 1 |
| Kallel, L | 1 |
| Fekih, M | 1 |
| Boubaker, J | 1 |
| Filali, A | 1 |
| Wang, Q | 1 |
| Selmi, C | 1 |
| Zhou, X | 1 |
| Qiu, D | 1 |
| Li, Z | 1 |
| Chen, X | 1 |
| Wang, J | 1 |
| Gershwin, ME | 2 |
| Ma, X | 1 |
| Franulović, OZ | 1 |
| Rajacić, N | 1 |
| Lesar, T | 1 |
| Kuna, AT | 1 |
| Morić, BV | 1 |
| Al-Shamma, S | 1 |
| Eross, B | 1 |
| Mclaughlin, S | 1 |
| Günther, R | 1 |
| Nasser, S | 2 |
| Hinrichsen, H | 2 |
| Fölsch, UR | 2 |
| Rumbo, C | 4 |
| Betzhold, J | 1 |
| Merati, S | 1 |
| Shneider, BL | 4 |
| Langley, PG | 1 |
| Underhill, J | 1 |
| Tredger, JM | 1 |
| Norris, S | 1 |
| McFarlane, IG | 5 |
| Löhr, HF | 1 |
| Takiguchi, J | 1 |
| Ohira, H | 1 |
| Rai, T | 1 |
| Shishido, S | 1 |
| Tojo, J | 1 |
| Sato, Y | 1 |
| Kasukawa, R | 1 |
| Watanabe, H | 1 |
| Funabashi, Y | 1 |
| Kumakawa, H | 1 |
| Emerick, KM | 1 |
| Emre, S | 2 |
| Muñoz Bertrán, E | 1 |
| Rosa Salazar, V | 1 |
| Hostalet Robles, F | 1 |
| Correa Estañ, JA | 1 |
| Belda Abad, G | 1 |
| Muñoz Ramírez, E | 1 |
| Uygur-Bayramiçli, O | 1 |
| Aydin, D | 1 |
| Ak, O | 1 |
| Karadayi, N | 1 |
| von Rainer Günther, ZB | 1 |
| Coverdale, SA | 1 |
| Field, J | 1 |
| Farrell, GC | 1 |
| Carpenter, HA | 5 |
| Biecker, E | 1 |
| Stieger, M | 1 |
| Zimmermann, A | 1 |
| Reichen, J | 1 |
| Nobili, V | 2 |
| Comparcola, D | 1 |
| Sartorelli, MR | 1 |
| Devito, R | 1 |
| Marcellini, M | 2 |
| Cheikh, I | 2 |
| Said, Y | 2 |
| Chaabouni, H | 2 |
| Ouerghi, H | 2 |
| Ben Ammar, A | 2 |
| Pariente, A | 1 |
| Luxon, BA | 2 |
| Kruchkovich, J | 1 |
| Blickstein, I | 1 |
| Binder, WL | 1 |
| Lewis, SJ | 1 |
| Nelson, VJ | 1 |
| Múzes, G | 1 |
| Gisbert, JP | 1 |
| González-Guijarro, L | 1 |
| Cara, C | 1 |
| Pajares, JM | 1 |
| Tranchida, P | 1 |
| Bayerl, M | 1 |
| Voelpel, MJ | 1 |
| Palutke, M | 1 |
| Hadjigogos, K | 1 |
| Marinaki, P | 1 |
| Bayer, EM | 1 |
| Kanzler, S | 2 |
| Tchuenbou, J | 1 |
| de Muret, A | 1 |
| Dumont, P | 1 |
| Bacq, Y | 1 |
| Brunt, EM | 1 |
| Di Bisceglie, AM | 1 |
| Petersen-Benz, C | 1 |
| Kasper, HU | 1 |
| Dries, V | 1 |
| Goeser, T | 1 |
| Bianchi, FB | 3 |
| Hokari, A | 1 |
| Zeniya, M | 1 |
| Aqel, BA | 1 |
| Machicao, V | 1 |
| Rosser, B | 1 |
| Satyanarayana, R | 1 |
| Harnois, DM | 1 |
| Dickson, RC | 1 |
| Heim, MH | 1 |
| Molmenti, EP | 2 |
| Malagó, M | 1 |
| Emre, SH | 1 |
| Burgess, MJ | 1 |
| Robson, K | 1 |
| Chaffins, M | 1 |
| Aparicio Pages, MN | 1 |
| de Boer, SY | 1 |
| Derijks, LJ | 1 |
| George, C | 1 |
| Buchel, E | 1 |
| van Steenbergen, W | 1 |
| Fevery, J | 1 |
| Dugan, C | 1 |
| Morotti, RA | 1 |
| Gondolesi, G | 1 |
| Bajaj, JS | 1 |
| Saeian, K | 1 |
| Varma, RR | 1 |
| Franco, J | 1 |
| Knox, JF | 1 |
| Podoll, J | 1 |
| Emmons, J | 1 |
| Levy, M | 1 |
| Binion, DG | 1 |
| Genova, NJ | 1 |
| Pappas, G | 2 |
| Ferri, S | 1 |
| Cassani, F | 2 |
| Shibata, M | 1 |
| Tan, P | 1 |
| Marotta, P | 1 |
| Ghent, C | 1 |
| Adams, P | 1 |
| Seela, S | 1 |
| Sheela, H | 1 |
| Boyer, JL | 1 |
| Choudhuri, G | 1 |
| Somani, SK | 1 |
| Baba, CS | 1 |
| Alexander, G | 1 |
| Liaskos, C | 1 |
| Luigi, G | 1 |
| Guidi, R | 1 |
| Francalanci, P | 1 |
| Maier, KP | 1 |
| Maíz, B | 1 |
| Odriozola, M | 1 |
| Blanco, A | 1 |
| Fernández, J | 1 |
| Castiella, A | 1 |
| Al-Chalabi, T | 2 |
| Guidi, M | 1 |
| Volta, U | 1 |
| Ferri, A | 1 |
| Duclos-Vallée, JC | 1 |
| Di Martino, V | 1 |
| Cazier, A | 1 |
| Yamamoto, AM | 1 |
| Emile, JF | 1 |
| Guettier, C | 1 |
| Coutarel, P | 1 |
| Cadranel, JF | 1 |
| Jarbandhan, SV | 1 |
| de Graaf, P | 1 |
| van Elburg, RM | 1 |
| van Bodegraven, AA | 1 |
| Allan, ML | 1 |
| Bornstein, JD | 1 |
| Muir, AJ | 1 |
| Tendler, DA | 1 |
| Montano-Loza, A | 1 |
| Piette, A | 1 |
| Murphy, D | 1 |
| Burlingame, R | 1 |
| Banerjee, S | 1 |
| Rahhal, R | 1 |
| Bishop, WP | 1 |
| Lee, YS | 1 |
| Iwasaki, Y | 1 |
| Terada, R | 1 |
| Okamaoto, R | 1 |
| Ikeda, H | 1 |
| Makino, Y | 1 |
| Kobashi, H | 1 |
| Takaguchi, K | 1 |
| Sakaguchi, K | 2 |
| Shiratori, Y | 1 |
| Cuarterolo, M | 2 |
| Velasco, CC | 1 |
| Ramonet, M | 2 |
| González, T | 2 |
| Garsd, A | 1 |
| Murray, KF | 1 |
| Tamori, A | 1 |
| Shinzaki, M | 1 |
| Kosaka, S | 1 |
| Hayashi, T | 1 |
| Iwai, S | 1 |
| Enomoto, M | 1 |
| Habu, D | 1 |
| Sakaguchi, H | 1 |
| Kawada, N | 1 |
| Hino, M | 1 |
| Shiomi, S | 1 |
| Nishiguchi, S | 1 |
| Targońska-Stepniak, B | 1 |
| Majdan, M | 1 |
| Suszek, D | 1 |
| Laskowska, K | 1 |
| Habib, S | 1 |
| Nalesnik, MA | 1 |
| Ahmad, J | 1 |
| BuchBarker, D | 1 |
| Shakil, AO | 1 |
| Montano Loza, AJ | 1 |
| Ishibashi, H | 1 |
| Shimoda, S | 1 |
| Reale, LD | 1 |
| Besa, EC | 1 |
| García Romero, R | 1 |
| Martín de Carpi, J | 1 |
| Bernal Cuartas, C | 1 |
| Pinillos Pisón, S | 1 |
| Varea Calderón, V | 1 |
| Gossard, AA | 1 |
| Lindor, KD | 2 |
| Sethi, NK | 1 |
| Torgovnick, J | 1 |
| Sethi, PK | 1 |
| Underhill, JA | 1 |
| Portmann, BC | 1 |
| van de Nadort, C | 1 |
| Houwen, RH | 1 |
| Stapelbroek, JM | 1 |
| Ahmed, K | 1 |
| Zucker, SD | 1 |
| Rivoire, C | 1 |
| Houlle, C | 1 |
| Bonnin, M | 1 |
| Cotte, B | 1 |
| Bolandard, F | 1 |
| Nohuz, E | 1 |
| Jardon, K | 1 |
| Rabischong, B | 1 |
| Canis, M | 1 |
| Mage, G | 1 |
| Hartmann, U | 1 |
| Schmitt, S | 1 |
| Reuss-Borst, M | 1 |
| Fracchia, M | 1 |
| Galatola, G | 1 |
| Pera, A | 1 |
| Foti, M | 1 |
| Tabone, M | 1 |
| Sawadogo, A | 1 |
| Boursier, J | 1 |
| Calès, P | 1 |
| Oberti, F | 1 |
| Schmidt, A | 1 |
| Luketic, VA | 1 |
| Gomez, DA | 1 |
| Sanyal, AJ | 1 |
| Shiffman, ML | 1 |
| Schlaak, JF | 1 |
| Gerken, G | 2 |
| Newton, JL | 1 |
| Burt, AD | 1 |
| Park, JB | 1 |
| Mathew, J | 1 |
| Bassendine, MF | 1 |
| James, OF | 1 |
| Hadzić, N | 1 |
| Davies, ET | 1 |
| Portmann, B | 1 |
| Donaldson, PT | 2 |
| Rela, M | 1 |
| Heaton, ND | 1 |
| Kaymakoglu, S | 1 |
| Cakaloglu, Y | 1 |
| Demir, K | 1 |
| Türkoglu, S | 1 |
| Badur, S | 1 |
| Gürel, S | 1 |
| Beşişik, F | 1 |
| Cevikbaş, U | 1 |
| Okten, A | 1 |
| Cañero-Velasco, C | 1 |
| Jara-Vega, P | 1 |
| Camarena, C | 1 |
| Brochu, P | 1 |
| Drut, R | 1 |
| Alvarez, E | 1 |
| Audeguy, P | 1 |
| Signoret, C | 1 |
| Nakamura, K | 1 |
| Makino, I | 1 |
| Agarwal, K | 1 |
| Jones, DE | 1 |
| Saksena, S | 1 |
| Elias, E | 1 |
| Sanada, I | 1 |
| Kawano, F | 1 |
| Tsukamoto, A | 1 |
| Kiyokawa, T | 1 |
| Perreaux, F | 1 |
| Zenaty, D | 1 |
| Capron, F | 1 |
| Trioche, P | 1 |
| Odièvre, M | 1 |
| Labrune, P | 1 |
| Richardson, PD | 1 |
| James, PD | 1 |
| Ryder, SD | 1 |
| Norris, SM | 1 |
| O'Grady, JG | 1 |
| Harrison, PM | 1 |
| López-Cepero Andrada, JM | 1 |
| Ferré Alamo, A | 1 |
| López Silva, M | 1 |
| Salado Fuentes, M | 1 |
| Benítez Roldán, A | 1 |
| Balakrishnan, C | 1 |
| Mangat, G | 1 |
| Kalke, S | 1 |
| Desai, D | 1 |
| Joshi, A | 1 |
| Deshpande, RB | 1 |
| Joshi, VR | 1 |
| Gish, RG | 1 |
| Mason, A | 1 |
| Löhr, H | 1 |
| Galle, PR | 1 |
| Yachha, SK | 1 |
| Chetri, K | 1 |
| Saraswat, VA | 1 |
| Krishnani, N | 1 |
| Andries, S | 1 |
| Casamayou, L | 1 |
| Sempoux, C | 1 |
| Burlet, M | 1 |
| Reding, R | 1 |
| Bernard Otte, J | 1 |
| Buts, JP | 1 |
| Sokal, E | 1 |
| Ozen, H | 1 |
| Koçak, N | 1 |
| Saltik, IN | 1 |
| Yüce, A | 1 |
| Gürakan, F | 1 |
| Al-Khalidi, JA | 1 |
| Lim, KN | 1 |
| Casanova, RL | 1 |
| Bruno, CJ | 1 |
| Takenami, T | 1 |
| Nishimura, M | 1 |
| Miyashita, M | 1 |
| Terao, M | 1 |
| Fujiwara, A | 1 |
| Tsuji, T | 1 |
| Kimura, KY | 1 |
| Seino, Y | 1 |
| Hirayama, Y | 1 |
| Aramaki, T | 1 |
| Yamaguchi, H | 1 |
| Amano, H | 1 |
| Takano, T | 1 |
| Netto, GJ | 1 |
| Murray, NG | 1 |
| Smith, DM | 1 |
| Molmenti, H | 1 |
| Crippin, JS | 1 |
| Hoover, TC | 1 |
| Jung, G | 1 |
| Marubashi, S | 1 |
| Sanchez, EQ | 1 |
| Gogel, B | 1 |
| Levy, MF | 1 |
| Goldstein, RM | 1 |
| Fasola, CG | 1 |
| Gonwa, TA | 1 |
| Klintmalm, GB | 1 |
| Kacar, S | 1 |
| Akdogan, M | 1 |
| Koşar, Y | 1 |
| Parlak, E | 1 |
| Sasmaz, N | 1 |
| Oguz, P | 1 |
| Aydog, G | 1 |
| Mohammad, S | 1 |
| Ustundag, G | 1 |
| Kuloglu, Z | 1 |
| Kirsaçlioğlu, CT | 1 |
| Kansu, A | 1 |
| Erden, E | 1 |
| Girgin, N | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy and Safety of Budesonide Capsules (3x3mg/d)Versus Prednisone in Patients With a Diagnose of Active Autoimmune Hepatitis. A Double-blind, Randomized, Active-controlled, Multicentre Study[NCT00838214] | Phase 2/Phase 3 | 208 participants (Actual) | Interventional | 2001-03-31 | Completed | ||
| Multicentric Study on the Long-term Follow-up of Autoimmune Hepatitis in the Pediatric Patients[NCT04247490] | 109 participants (Actual) | Observational | 2019-12-17 | Completed | |||
| Multicenter, Nationwide, Observational, Retrospective and Prospective Study Based on the Development of a Autoimmune Hepatitis Patient's Database Linked to a Biological Sample Storage[NCT06078098] | 10,000 participants (Anticipated) | Observational [Patient Registry] | 2023-03-29 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
82 reviews available for azathioprine and Autoimmune Chronic Hepatitis
| Article | Year |
|---|---|
Pediatric Autoimmune Liver Diseases: Autoimmune Hepatitis and Primary Sclerosing Cholangitis.
Topics: Adolescent; Asymptomatic Diseases; Autoimmune Diseases; Azathioprine; Biomarkers; Child; Cholangitis | 2021 |
Pathogenesis of Autoimmune Hepatitis-Cellular and Molecular Mechanisms.
Topics: Animals; Azathioprine; DNA Methylation; Epigenesis, Genetic; Glucocorticoids; Hepatitis, Autoimmune; | 2021 |
Noninvasive biomarkers for the diagnosis and management of autoimmune hepatitis.
Topics: Azathioprine; Biomarkers; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis; | 2022 |
Autoimmune hepatitis: Challenges and novelties.
Topics: Autoantibodies; Azathioprine; Female; Hepatitis, Autoimmune; Humans; Immunoglobulin G; Immunosuppres | 2022 |
Recent advances in the diagnosis and management of autoimmune hepatitis.
Topics: Autoantibodies; Azathioprine; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Mycophenolic | 2022 |
[Treatment of Autoimmune Hepatitis].
Topics: Adult; Azathioprine; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Mycophenolic Acid; Tac | 2023 |
Corticosteroid-refractory autoimmune hepatitis after COVID-19 vaccination: a case report and literature review.
Topics: Adrenal Cortex Hormones; Azathioprine; COVID-19; COVID-19 Vaccines; Female; Hepatitis, Autoimmune; H | 2023 |
Treatment of Autoimmune Hepatitis.
Topics: Adrenal Cortex Hormones; Azathioprine; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Myco | 2024 |
Autoconversion of Autoimmune Liver Diseases.
Topics: Adult; Autoantibodies; Autoimmunity; Azathioprine; Biomarkers; Cholagogues and Choleretics; Diagnost | 2020 |
Clinical management of autoimmune hepatitis.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Autoantibodies; Azathioprine; Disease Progression | 2019 |
Autoimmune Hepatitis: 2019 Update.
Topics: Autoantibodies; Azathioprine; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Quality of Li | 2020 |
Review article: opportunities to improve and expand thiopurine therapy for autoimmune hepatitis.
Topics: Allopurinol; Azathioprine; Drug-Related Side Effects and Adverse Reactions; Guanine Nucleotides; Hep | 2020 |
Recent updates on the management of autoimmune hepatitis.
Topics: Autoantibodies; Azathioprine; Hepatitis, Autoimmune; Humans; Mycophenolic Acid; Quality of Life | 2021 |
Systematic Review and Meta-Analysis of Thiopurine Metabolite Levels and Biochemical Remission in Autoimmune Hepatitis.
Topics: Adult; Azathioprine; Child; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Mercaptopurine; | 2021 |
Autoimmune hepatitis: From current knowledge and clinical practice to future research agenda.
Topics: Animals; Azathioprine; Drug Therapy, Combination; Glucocorticoids; Hepatitis, Autoimmune; Humans; Im | 2018 |
Second-line Agents in Pediatric Patients With Autoimmune Hepatitis: A Systematic Review and Meta-analysis.
Topics: Azathioprine; Child; Cyclosporine; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Inductio | 2017 |
Autoimmune hepatitis: Standard treatment and systematic review of alternative treatments.
Topics: Adult; Age Factors; Azathioprine; Child; Complementary Therapies; Drug Hypersensitivity; Glucocortic | 2017 |
[Autoimmune hepatitis-standard and second-line therapy].
Topics: Azathioprine; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Transplantation; Predni | 2018 |
Clinical narrative: autoimmune hepatitis.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Autoantibodies; Azathioprine; Biopsy; Cycl | 2018 |
Autoimmune Hepatitis in the Elderly: Diagnosis and Pharmacologic Management.
Topics: Age Factors; Azathioprine; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Prednisone | 2018 |
Juvenile autoimmune hepatitis: A comprehensive review.
Topics: Adolescent; Adult; Autoantibodies; Azathioprine; Child; Cholangitis, Sclerosing; Disease Management; | 2018 |
De novo autoimmune hepatitis -is this different in adults compared to children?
Topics: Adult; Age Factors; Autoantibodies; Azathioprine; Child; Female; Graft Rejection; Hepatitis C; Hepat | 2018 |
Novel therapeutic targets in autoimmune hepatitis.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Autoantibodies; Azathioprine; Cell- and Tissue-Base | 2018 |
Grand round: Autoimmune hepatitis.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Azathioprine; Clinical Decision-Making; Complementary T | 2019 |
Stopping immunosuppressive treatment in autoimmune hepatitis (AIH): Is it justified (and in whom and when)?
Topics: Azathioprine; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Patient Selection; Prednisolo | 2019 |
Autoimmune hepatitis: Current and future therapeutic options.
Topics: Animals; Azathioprine; Disease Management; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; | 2019 |
Systematic review with meta-analysis: mycophenolate mofetil as a second-line therapy for autoimmune hepatitis.
Topics: Antibiotics, Antineoplastic; Azathioprine; Drug-Related Side Effects and Adverse Reactions; Female; | 2019 |
Comparison of mycophenolate mofetil with standard treatment for autoimmune hepatitis: a meta-analysis.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Azathioprine; Glucocorticoids; Hepatitis, Autoimm | 2019 |
Autoimmune hepatitis treatment in the elderly: A systematic review.
Topics: Age Factors; Aged; Azathioprine; Disease Progression; Drug Therapy, Combination; Glucocorticoids; He | 2019 |
Amicrobial pustulosis of the folds associated with autoimmune disorders: systemic lupus erythematosus case series and first report on the association with autoimmune hepatitis.
Topics: Adult; Antirheumatic Agents; Azathioprine; Chloroquine; Dapsone; Diagnosis, Differential; Drug Thera | 2013 |
Immunoglobulin G4-associated de novo autoimmune hepatitis after liver transplantation for chronic hepatitis B- and C-related cirrhosis and hepatocellular carcinoma: a case report with literature review.
Topics: Antiviral Agents; Azathioprine; Carcinoma, Hepatocellular; Coinfection; Drug Therapy, Combination; H | 2013 |
Review article: autoimmune hepatitis -- current management and challenges.
Topics: Animals; Autoantibodies; Azathioprine; Female; Hepatitis, Autoimmune; Humans; Immunoglobulin G; Immu | 2013 |
Current and prospective pharmacotherapy for autoimmune hepatitis.
Topics: Adrenal Cortex Hormones; Animals; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Budesonide; | 2014 |
Autoimmune hepatitis: an approach to disease understanding and management.
Topics: Azathioprine; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Transp | 2015 |
Autoimmune hepatitis: Unveiling faces.
Topics: Anti-Inflammatory Agents; Azathioprine; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liv | 2015 |
Management of Difficult Cases of Autoimmune Hepatitis.
Topics: Acute Disease; Azathioprine; Female; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunosuppressi | 2016 |
Diagnosis and Management of Autoimmune Hepatitis: Current Status and Future Directions.
Topics: Anti-Inflammatory Agents; Autoantibodies; Azathioprine; Biomarkers; Diagnosis, Differential; Drug Th | 2016 |
Cutting edge issues in autoimmune hepatitis.
Topics: Azathioprine; Drug Therapy, Combination; Genetic Predisposition to Disease; Hepatitis, Autoimmune; H | 2016 |
The use of immunosuppression in autoimmune hepatitis: A current literature review.
Topics: Azathioprine; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Mycophenolic Acid; Prednisolo | 2017 |
Current status of autoimmune hepatitis in Japan.
Topics: Adrenal Cortex Hormones; Azathioprine; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Japa | 2008 |
Management of autoimmune liver disease.
Topics: Autoantibodies; Azathioprine; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellul | 2009 |
Current and future treatments of autoimmune hepatitis.
Topics: Adrenal Cortex Hormones; Azathioprine; Dose-Response Relationship, Drug; Drug Therapy, Combination; | 2009 |
Treatment options for autoimmune hepatitis: a systematic review of randomized controlled trials.
Topics: Azathioprine; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Prednisolone; Prednisone; Ran | 2010 |
Autoimmune hepatitis.
Topics: Animals; Azathioprine; Budesonide; Diagnosis, Differential; Drug Therapy, Combination; Genetic Predi | 2010 |
Autoimmune hepatitis.
Topics: Algorithms; Azathioprine; Carcinoma, Hepatocellular; Clinical Trials as Topic; Female; Hepatitis, Au | 2011 |
Pharmacological management of autoimmune hepatitis.
Topics: Adult; Azathioprine; Child; Disease Progression; End Stage Liver Disease; Hepatitis, Autoimmune; Hum | 2011 |
Management of autoimmune hepatitis.
Topics: Azathioprine; Budesonide; Drug Hypersensitivity; Hepatitis, Autoimmune; Humans; Immunosuppressive Ag | 2011 |
Mycophenolate mofetil as a rescue therapy for autoimmune hepatitis patients who are not responsive to standard therapy.
Topics: Azathioprine; Drug Therapy, Combination; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Ag | 2011 |
Budesonide for the treatment of autoimmune hepatitis.
Topics: Azathioprine; Budesonide; Drug Labeling; Glucocorticoids; Hepatitis, Autoimmune; Humans; Prednisone | 2011 |
The treatment of autoimmune hepatitis.
Topics: Azathioprine; Budesonide; Cyclosporine; Hepatitis, Autoimmune; Humans; Mycophenolic Acid | 2012 |
Autoimmune hepatitis type 2 associated with an unexpected and transient presence of primary biliary cirrhosis-specific antimitochondrial antibodies: a case study and review of the literature.
Topics: Antibodies, Anti-Idiotypic; Azathioprine; Child, Preschool; Female; Glucocorticoids; Hepatitis, Auto | 2012 |
[Autoimmune hepatitis and overlap syndrome: therapy].
Topics: Azathioprine; Cholangitis, Sclerosing; Drug Therapy, Combination; Haplotypes; Hepatitis, Autoimmune; | 2002 |
Autoimmune hepatitis overlapping with primary sclerosing cholangitis.
Topics: Adult; Autoantibodies; Azathioprine; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis, S | 2002 |
[Autoimmune hepatitis caused by acute hepatitis due to hepatitis A virus].
Topics: Acute Disease; Adult; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Autoa | 2002 |
Autoimmune hepatitis in children.
Topics: Autoantibodies; Azathioprine; Child; Cholangitis, Sclerosing; Female; Hepatitis, Autoimmune; HLA-DR3 | 2002 |
Treatment strategies in autoimmune hepatitis.
Topics: Azathioprine; Budesonide; Clinical Trials as Topic; Cyclosporine; Disease Progression; Hepatitis, Au | 2002 |
Treatment of autoimmune hepatitis.
Topics: Adult; Age Factors; Anti-Inflammatory Agents; Azathioprine; Child; Drug Administration Schedule; Dru | 2002 |
[Auto-immune hepatitis: therapeutic management].
Topics: Anti-Inflammatory Agents; Antimetabolites; Azathioprine; Calcineurin Inhibitors; Cyclophosphamide; C | 2003 |
Autoimmune hepatitis. Making sense of all those antibodies.
Topics: Adult; Algorithms; Anti-Inflammatory Agents; Antibodies, Antinuclear; Asialoglycoprotein Receptor; A | 2003 |
Emerging treatments for autoimmune hepatitis.
Topics: Azathioprine; Calcineurin Inhibitors; Cytokines; Dose-Response Relationship, Drug; Drug Therapy, Com | 2002 |
[Treatment of autoimmune hepatitis].
Topics: Azathioprine; Folic Acid Antagonists; Hepatitis, Autoimmune; Humans; Immunity, Cellular; Immunosuppr | 2003 |
[Autoimmune liver disease: diagnosis and therapy].
Topics: Adult; Autoantibodies; Autoimmune Diseases; Azathioprine; Biopsy; Child; Cholagogues and Choleretics | 2004 |
[Difference between autoimmune hepatitis (AIH) with and without hepatitis C virus (HCV)].
Topics: Adrenal Cortex Hormones; Antiviral Agents; Autoantibodies; Azathioprine; Disease Susceptibility; Dru | 2004 |
[Autoimmune hepatitis].
Topics: Anti-Inflammatory Agents; Azathioprine; Diagnosis, Differential; Drug Therapy, Combination; Female; | 2004 |
Promising treatment of autoimmune hepatitis with 6-thioguanine after adverse events on azathioprine.
Topics: Aged; Aged, 80 and over; Azathioprine; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agen | 2005 |
[Autoimmune hepatitis].
Topics: Antibodies, Antinuclear; Antigen Presentation; Autoantibodies; Autoantigens; Azathioprine; CD4-Posit | 2005 |
[Drug therapy in chronic liver disease].
Topics: Adenine; Administration, Oral; Anti-HIV Agents; Antiviral Agents; Azathioprine; Cholangitis, Scleros | 2005 |
Autoimmune hepatitis.
Topics: Anti-Inflammatory Agents; Autoantibodies; Azathioprine; Diagnosis, Differential; Drug Therapy, Combi | 2006 |
Cost-effectiveness of pharmacotherapy for autoimmune hepatitis.
Topics: Adrenal Cortex Hormones; Azathioprine; Cost-Benefit Analysis; Hepatitis, Autoimmune; Humans; Immunol | 2006 |
Autoimmune hepatitis: diagnosis, treatment, and prognosis.
Topics: Algorithms; Autoantibodies; Azathioprine; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; P | 2006 |
[Autoimmune liver diseases and their overlap syndromes].
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Antinuclear; Autoantibodies; Autoimmune Diseases; Azath | 2006 |
[Autoimmune hepatitis: recent update on diagnosis and treatment].
Topics: Adolescent; Adult; Aged; Autoantibodies; Azathioprine; Child; Child, Preschool; Drug Therapy, Combin | 2006 |
Current therapy for autoimmune hepatitis.
Topics: Adult; Age Factors; Aged; Azathioprine; Biopsy, Needle; Disease Progression; Drug Therapy, Combinati | 2007 |
Rituximab in autoimmune pancytopenia: a case report and review of literature.
Topics: Adult; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived | 2007 |
Clinical features, differential diagnosis and treatment of autoimmune hepatitis in the elderly.
Topics: Aged; Azathioprine; Diagnosis, Differential; Drug Therapy, Combination; Glucocorticoids; Hepatitis, | 2008 |
Safety issues in the management of autoimmune hepatitis.
Topics: Azathioprine; Drug Therapy, Combination; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunosuppr | 2008 |
Drug therapy in the management of type 1 autoimmune hepatitis.
Topics: Azathioprine; Disease Susceptibility; Drug Therapy, Combination; Female; Glucocorticoids; Hepatitis, | 1999 |
[Autoimmune hepatitis: progress in its treatment].
Topics: Azathioprine; Female; Hepatitis C, Chronic; Hepatitis, Autoimmune; Humans; Middle Aged; Prednisolone | 1999 |
Wilson's disease with superimposed autoimmune features: report of two cases and review.
Topics: Adolescent; Adult; Azathioprine; Copper; Diagnostic Errors; Female; Glucocorticoids; Hepatitis, Auto | 2000 |
Autoimmune liver disease. Current standards, future directions.
Topics: Anti-Inflammatory Agents; Autoimmune Diseases; Azathioprine; Cholagogues and Choleretics; Cholangiti | 2001 |
Current concepts in the diagnosis, pathogenesis, and treatment of autoimmune hepatitis.
Topics: Age Distribution; Anti-Inflammatory Agents; Azathioprine; Causality; Drug Therapy, Combination; Euro | 2001 |
Current and novel immunosuppressive therapy for autoimmune hepatitis.
Topics: Adrenal Cortex Hormones; Azathioprine; Drug Therapy, Combination; Hepatitis, Autoimmune; Humans; Imm | 2002 |
12 trials available for azathioprine and Autoimmune Chronic Hepatitis
| Article | Year |
|---|---|
First Results From a Propensity Matching Trial of Mycophenolate Mofetil vs. Azathioprine in Treatment-Naive AIH Patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azathioprine; Drug Therapy, Combination; Female; Hepatit | 2021 |
Assessing the efficacy and safety of mycophenolate mofetil versus azathioprine in patients with autoimmune hepatitis (CAMARO trial): study protocol for a randomised controlled trial.
Topics: Adult; Azathioprine; End Stage Liver Disease; Hepatitis, Autoimmune; Humans; Immunosuppressive Agent | 2022 |
Assessing the efficacy and safety of mycophenolate mofetil versus azathioprine in patients with autoimmune hepatitis (CAMARO trial): study protocol for a randomised controlled trial.
Topics: Adult; Azathioprine; End Stage Liver Disease; Hepatitis, Autoimmune; Humans; Immunosuppressive Agent | 2022 |
Assessing the efficacy and safety of mycophenolate mofetil versus azathioprine in patients with autoimmune hepatitis (CAMARO trial): study protocol for a randomised controlled trial.
Topics: Adult; Azathioprine; End Stage Liver Disease; Hepatitis, Autoimmune; Humans; Immunosuppressive Agent | 2022 |
Assessing the efficacy and safety of mycophenolate mofetil versus azathioprine in patients with autoimmune hepatitis (CAMARO trial): study protocol for a randomised controlled trial.
Topics: Adult; Azathioprine; End Stage Liver Disease; Hepatitis, Autoimmune; Humans; Immunosuppressive Agent | 2022 |
Autoimmune Hepatitis in Children: Prednisone Plus Azathioprine Versus Cyclosporine: A Randomized Trial.
Topics: Azathioprine; Child; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Hepatitis, Autoimmune | 2020 |
Rituximab for the treatment of patients with autoimmune hepatitis who are refractory or intolerant to standard therapy.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Aspartate Aminotransferases; Azathioprine; Chem | 2013 |
Budesonide versus prednisone with azathioprine for the treatment of autoimmune hepatitis in children and adolescents.
Topics: Adolescent; Alanine Transaminase; Aspartate Aminotransferases; Azathioprine; Budesonide; Child; Chil | 2013 |
Protocol of a prospective study for the combination treatment of Shu-Gan-jian-Pi decoction and steroid standard therapy in autoimmune hepatitis patients.
Topics: Azathioprine; Clinical Protocols; Drugs, Chinese Herbal; Glucocorticoids; Hepatitis, Autoimmune; Hum | 2016 |
Thiopurine methyltransferase phenotype and genotype in relation to azathioprine therapy in autoimmune hepatitis.
Topics: Adolescent; Adult; Aged; Azathioprine; Erythrocytes; Female; Genotype; Hepatitis, Autoimmune; Humans | 2002 |
How reversible is hepatic functional impairment in autoimmune hepatitis?
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Antipyrine; Azathioprine; Drug Therapy, Combinati | 2003 |
Diagnostic and therapeutic implications of bile duct injury in autoimmune hepatitis.
Topics: Adrenal Cortex Hormones; Adult; Autoantibodies; Azathioprine; Bile Ducts; Cell Nucleus; Cholangitis; | 2004 |
Efficacy of tacrolimus in the treatment of steroid refractory autoimmune hepatitis.
Topics: Adult; Aged; Aged, 80 and over; Azathioprine; Biopsy; Female; Fibrosis; Follow-Up Studies; Hepatitis | 2004 |
Short-term cyclosporine induces a remission of autoimmune hepatitis in children.
Topics: Adolescent; Alanine Transaminase; Anti-Inflammatory Agents; Azathioprine; Child; Child, Preschool; C | 1999 |
Failure of budesonide in a pilot study of treatment-dependent autoimmune hepatitis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Bone Density; Budesonide; Female; Femur; Hepati | 2000 |
239 other studies available for azathioprine and Autoimmune Chronic Hepatitis
| Article | Year |
|---|---|
Autoimmune hepatitis triggered by COVID-19: A report of two cases.
Topics: Azathioprine; COVID-19; Hepatitis, Autoimmune; Humans; SARS-CoV-2 | 2021 |
Reply to: "The search for optimum thiopurine metabolite levels in autoimmune hepatitis continues…".
Topics: Azathioprine; Hepatitis, Autoimmune; Humans; Inflammatory Bowel Diseases | 2022 |
[Autoimmune Hepatitis - What is important for clinical practice?]
Topics: Autoantibodies; Azathioprine; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunosuppressive Agen | 2022 |
Coexistence of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome and membranous nephropathy: A case report.
Topics: Azathioprine; Glomerulonephritis, Membranous; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliar | 2023 |
Autoimmune hepatitis unmasked by dengue infection - An unexplored and rare association.
Topics: Azathioprine; Dengue; Female; Hepatitis, Autoimmune; Humans; Liver Diseases | 2023 |
Chronic hepatitis E in an elderly immunocompetent patient who achieved a sustained virologic response with ribavirin treatment.
Topics: Adult; Aged; Antiviral Agents; Azathioprine; Female; Hepatitis E; Hepatitis E virus; Hepatitis, Auto | 2023 |
Chronic hepatitis E in an elderly immunocompetent patient who achieved a sustained virologic response with ribavirin treatment.
Topics: Adult; Aged; Antiviral Agents; Azathioprine; Female; Hepatitis E; Hepatitis E virus; Hepatitis, Auto | 2023 |
Chronic hepatitis E in an elderly immunocompetent patient who achieved a sustained virologic response with ribavirin treatment.
Topics: Adult; Aged; Antiviral Agents; Azathioprine; Female; Hepatitis E; Hepatitis E virus; Hepatitis, Auto | 2023 |
Chronic hepatitis E in an elderly immunocompetent patient who achieved a sustained virologic response with ribavirin treatment.
Topics: Adult; Aged; Antiviral Agents; Azathioprine; Female; Hepatitis E; Hepatitis E virus; Hepatitis, Auto | 2023 |
Chronic hepatitis E in an elderly immunocompetent patient who achieved a sustained virologic response with ribavirin treatment.
Topics: Adult; Aged; Antiviral Agents; Azathioprine; Female; Hepatitis E; Hepatitis E virus; Hepatitis, Auto | 2023 |
Chronic hepatitis E in an elderly immunocompetent patient who achieved a sustained virologic response with ribavirin treatment.
Topics: Adult; Aged; Antiviral Agents; Azathioprine; Female; Hepatitis E; Hepatitis E virus; Hepatitis, Auto | 2023 |
Chronic hepatitis E in an elderly immunocompetent patient who achieved a sustained virologic response with ribavirin treatment.
Topics: Adult; Aged; Antiviral Agents; Azathioprine; Female; Hepatitis E; Hepatitis E virus; Hepatitis, Auto | 2023 |
Chronic hepatitis E in an elderly immunocompetent patient who achieved a sustained virologic response with ribavirin treatment.
Topics: Adult; Aged; Antiviral Agents; Azathioprine; Female; Hepatitis E; Hepatitis E virus; Hepatitis, Auto | 2023 |
Chronic hepatitis E in an elderly immunocompetent patient who achieved a sustained virologic response with ribavirin treatment.
Topics: Adult; Aged; Antiviral Agents; Azathioprine; Female; Hepatitis E; Hepatitis E virus; Hepatitis, Auto | 2023 |
Long-term outcomes of patients with type 1 or 2 autoimmune hepatitis presenting in childhood.
Topics: Adolescent; Adult; Azathioprine; Child; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Pro | 2023 |
Treatment of autoimmune hepatitis: Budesonide does not solve our problems.
Topics: Azathioprine; Budesonide; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Prednisone | 2023 |
Long-term Outcome of Autoimmune Hepatitis: Consecutive Patient Cohort and Data on the Second Twenty Years.
Topics: Azathioprine; Disease Progression; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Recurren | 2023 |
Epidemiology, clinical features and management of autoimmune hepatitis in Switzerland: a retrospective and prospective cohort study.
Topics: Adolescent; Adult; Azathioprine; Budesonide; Child; Child, Preschool; Cohort Studies; Female; Hepati | 2023 |
The efficacy and adverse effects of budesonide in remission induction treatment of autoimmune hepatitis: a retrospective study.
Topics: Adult; Aged; Azathioprine; Budesonide; Drug Therapy, Combination; Female; Hepatitis, Autoimmune; Hum | 2019 |
Profiling the patient with autoimmune hepatitis on calcineurin inhibitors: a real-world-experience.
Topics: Adult; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Female; Glucocorticoids; Hepatitis, Autoi | 2020 |
Characteristics and Outcomes of Autoimmune Hepatitis from a Tertiary Paediatric Centre, Cape Town, South Africa.
Topics: Autoantibodies; Azathioprine; Biopsy; Child; Child, Preschool; Cholangiopancreatography, Magnetic Re | 2020 |
High discontinuation rate of azathioprine in autoimmune hepatitis, independent of time of treatment initiation.
Topics: Azathioprine; Europe; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Retrospective Studies | 2020 |
Azathioprine Monotherapy Is Equivalent to Dual Therapy in Maintaining Remission in Autoimmune Hepatitis.
Topics: Aged; Aged, 80 and over; Azathioprine; Drug Therapy, Combination; Female; Glucocorticoids; Hepatitis | 2021 |
Discontinuation rate of azathioprine.
Topics: Azathioprine; Crohn Disease; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents | 2020 |
Long-term outcome of patients with difficult-to-treat autoimmune hepatitis receiving mycophenolate mofetil.
Topics: Azathioprine; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Mycophenolic Acid; Prednisolo | 2021 |
Autoantibodies to intracellular "rods and rings" structures in two patients with autoimmune hepatitis treated with azathioprine.
Topics: Adolescent; Adult; Aged; Autoantibodies; Autoantigens; Azathioprine; Child; Drug Monitoring; Female; | 2020 |
Discontinuation rate of azathioprine.
Topics: Azathioprine; Crohn Disease; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents | 2020 |
IgG 4 Autoimmune Hepatitis Presenting as Idiopathic Hypereosinophilia Syndrome.
Topics: Azathioprine; Female; Glucocorticoids; Hepatitis, Autoimmune; Humans; Hypereosinophilic Syndrome; Im | 2021 |
Efficiency of azathioprine monotherapy for maintenance treatment of autoimmune hepatitis in children.
Topics: Adolescent; Azathioprine; Child; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Ma | 2022 |
Clinical characteristics of paediatric autoimmune hepatitis at a referral hospital in Sub Saharan Africa.
Topics: Adolescent; Autoantibodies; Azathioprine; Child; Child, Preschool; Drug Therapy, Combination; Female | 2020 |
[Second-line therapy with mycophenolate mofetil in patients with autoimmune hepatitis who were intolerant or failed to respond to standard treatment].
Topics: Adult; Aged; Azathioprine; Europe; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; | 2021 |
Association of genetic variants in TPMT, ITPA, and NUDT15 with azathioprine-induced myelosuppression in southwest china patients with autoimmune hepatitis.
Topics: Adult; Aged; Alleles; Azathioprine; China; Female; Genetic Association Studies; Guanine Nucleotides; | 2021 |
Maintenance immunosuppressive therapy in autoimmune hepatitis: To stop or not to stop, that is the question.
Topics: Azathioprine; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents | 2021 |
The search for optimum thiopurine metabolite levels in autoimmune hepatitis continues….
Topics: Azathioprine; Hepatitis, Autoimmune; Humans | 2022 |
Autoimmune hepatitis triggered by SARS-CoV-2 vaccination.
Topics: 2019-nCoV Vaccine mRNA-1273; Aged; Autoantibodies; Azathioprine; Carcinoma, Transitional Cell; Causa | 2021 |
Enrichment of Genetic Variants in the Glucocorticoid Receptor Signalling Pathway in Autoimmune Hepatitis with Failure of Standard Treatment.
Topics: Adolescent; Adult; Aged; Azathioprine; Child; Cohort Studies; Denmark; Drug Resistance, Multiple; Fe | 2017 |
Antimitochondrial antibodies positive autoimmune hepatitis with acute onset.
Topics: Autoantibodies; Azathioprine; Biopsy; Female; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immuno | 2017 |
Development of autoimmune hepatitis in a psoriasis patient without immunosuppressive therapy.
Topics: Aged; Alanine Transaminase; Aspartate Aminotransferases; Azathioprine; Drug Therapy, Combination; He | 2017 |
Autoimmune severe acute fulminant hepatic failure (FHF) during pregnancy.
Topics: Abortion, Spontaneous; Adrenal Cortex Hormones; Adult; Azathioprine; Diagnosis, Differential; Early | 2018 |
Pediatric Autoimmune Hepatitis: What Do You Do When First-line Therapy Fails?
Topics: Azathioprine; Child; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Transplantation | 2017 |
IgG4-related disease: long-term natural history and management of a relapsing multisystem disease entity.
Topics: Autoimmune Diseases; Azathioprine; Diagnosis, Differential; Hepatitis, Autoimmune; Humans; Immunoglo | 2017 |
Mogamulizumab-induced toxicoderma-like eruptions and autoimmune hepatitis successfully treated with azathioprine in adult T-cell leukaemia/lymphoma.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Azathioprine; Drug Eruptions; Female; Hepa | 2017 |
Population-based prevalence, incidence, and disease burden of autoimmune hepatitis in South Korea.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Azathioprine; Carcinoma, Hepato | 2017 |
Rare gene variants in a patient with azathioprine-induced lethal myelosuppression.
Topics: Azathioprine; Bone Marrow Diseases; Cholangitis, Sclerosing; Ethnicity; Genetic Predisposition to Di | 2017 |
Treatment Response and Outcome with Two Different Prednisolone Regimens in Autoimmune Hepatitis.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Drug Administration Schedule; Drug | 2017 |
HMG CoA reductase inhibitor associated myositis and autoimmune hepatitis.
Topics: Aged; Anti-Inflammatory Agents; Azathioprine; Diabetes Mellitus, Type 2; Fatal Outcome; Female; Hepa | 2017 |
The Best Choice for Second-line Agent in Standard Treatment-refractory Children With Autoimmune Hepatitis.
Topics: Azathioprine; Child; Hepatitis, Autoimmune; Humans; Mycophenolic Acid | 2018 |
New predictive factors of poor response to therapy in autoimmune hepatitis: role of mean platelet volume.
Topics: Adult; Age of Onset; Anti-Inflammatory Agents; Azathioprine; Drug Therapy, Combination; Female; Hepa | 2017 |
New presentation of autoimmune hepatitis with erythema multiforme.
Topics: Azathioprine; Erythema Multiforme; Female; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunosup | 2018 |
Budesonide in Autoimmune Hepatitis: The Right Drug at the Right Time for the Right Patient.
Topics: Alanine Transaminase; Azathioprine; Budesonide; Hepatitis, Autoimmune; Humans | 2018 |
Azathioprine-induced reversible EBV-associated Hodgkin-like lymphoma after immunosuppressive therapy for autoimmune hepatitis
.
Topics: Azathioprine; Epstein-Barr Virus Infections; Hepatitis, Autoimmune; Herpesvirus 4, Human; Humans; Im | 2018 |
Primary cutaneous amyloidosis associated with autoimmune hepatitis-primary biliary cirrhosis overlap syndrome and Sjögren syndrome: A case report.
Topics: Amyloidosis, Familial; Anti-Inflammatory Agents; Azathioprine; Cholagogues and Choleretics; Drug The | 2018 |
Clinical and prognostic implications of acute onset of Autoimmune Hepatitis: An Italian multicentre study.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Azathioprine; Bi | 2018 |
Unmet needs and new models for future trials in autoimmune hepatitis.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Biomarkers; Child; Disease Progression; Hepatitis, Aut | 2018 |
Biochemical efficacy of tioguanine in autoimmune hepatitis: a retrospective review of practice in the Netherlands.
Topics: Adolescent; Adult; Aged; Azathioprine; Biomarkers; Child; Drug-Related Side Effects and Adverse Reac | 2018 |
Lower 6-MMP/6-TG Ratio May Be a Therapeutic Target in Pediatric Autoimmune Hepatitis.
Topics: Allopurinol; Antimetabolites; Azathioprine; Child; Female; Guanine Nucleotides; Hepatitis, Autoimmun | 2018 |
The Saudi association for the study of liver diseases and transplantation clinical practice guidelines for management of autoimmune hepatitis.
Topics: Adult; Azathioprine; Female; Fibrosis; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Live | 2018 |
Mycophenolate mofetil treatment in patients with autoimmune hepatitis failing standard therapy with prednisolone and azathioprine.
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Azathioprine; Drug Monitoring; Drug Resistance; Drug | 2019 |
Healing of autoimmune hepatitis associated with hepatitis C virus infection treated with direct-acting antivirals.
Topics: Antiviral Agents; Azathioprine; Benzimidazoles; Female; Fluorenes; Hepatitis C, Chronic; Hepatitis, | 2019 |
Long-term follow-up of children and young adults with autoimmune hepatitis treated with cyclosporine.
Topics: Adolescent; Azathioprine; Child; Child, Preschool; Cholangitis, Sclerosing; Cyclosporine; Drug Thera | 2019 |
Autoimmune hepatitis in patients with multiple sclerosis: The role of immunomodulatory treatment.
Topics: Adult; Autoantibodies; Azathioprine; Female; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunol | 2019 |
Presentation and Outcomes of Pregnancy in Patients With Autoimmune Hepatitis.
Topics: Abortion, Spontaneous; Adult; Alanine Transaminase; Aspartate Aminotransferases; Azathioprine; Cohor | 2019 |
Predniso(lo)ne Dosage and Chance of Remission in Patients With Autoimmune Hepatitis.
Topics: Adult; Aged; Azathioprine; Dose-Response Relationship, Drug; Europe; Female; Glucocorticoids; Hepati | 2019 |
Steroid Free Treatment of Autoimmune Hepatitis in Selected Children.
Topics: Adolescent; Alanine Transaminase; Antibodies, Antineutrophil Cytoplasmic; Azathioprine; Biomarkers; | 2019 |
Frequency of Hepatobiliary Manifestations and Concomitant Liver Disease in Inflammatory Bowel Disease Patients.
Topics: Adult; Azathioprine; Cholelithiasis; Colitis, Ulcerative; Crohn Disease; Cross-Sectional Studies; Fe | 2019 |
Steroid free treatment in autoimmune hepatitis: Is azathioprine monotherapy truly a viable option to obtain remission?
Topics: Azathioprine; Child; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents | 2019 |
Biliary features in liver histology of children with autoimmune liver disease.
Topics: Adolescent; Azathioprine; Child; Child, Preschool; Cholangitis; Cholangitis, Sclerosing; Drug Therap | 2019 |
Immune-mediated Drug-induced Liver Injury Caused by Laninamivir Octanoate Hydrate.
Topics: Adolescent; Antiviral Agents; Azathioprine; Chemical and Drug Induced Liver Injury; Female; Guanidin | 2019 |
Autoimmune liver disease following acute hepatitis A infection.
Topics: Acute Disease; Administration, Oral; Adult; Anti-Inflammatory Agents; Azathioprine; Diagnosis, Diffe | 2019 |
Autoimmune hepatitis following Epstein-Barr virus infection: a diagnostic dilemma.
Topics: Adult; Azathioprine; Diagnosis, Differential; Epstein-Barr Virus Infections; Glucocorticoids; Hepati | 2019 |
Autoimmune hepatitis in southern Israel: a 15-year multicenter study.
Topics: Adult; Azathioprine; Biopsy; Budesonide; Drug Therapy, Combination; Female; Glucocorticoids; Hepatit | 2013 |
Azathioprine-induced fever in autoimmune hepatitis.
Topics: Azathioprine; Female; Fever; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Middle Aged; W | 2013 |
Budesonide for juvenile autoimmune hepatitis? Not yet.
Topics: Azathioprine; Budesonide; Female; Hepatitis, Autoimmune; Humans; Male; Prednisone | 2013 |
Humoral immune mechanism of liver injury in giant cell hepatitis with autoimmune hemolytic anemia.
Topics: Anemia, Hemolytic, Autoimmune; Anti-Inflammatory Agents; Antibodies, Monoclonal, Murine-Derived; Aut | 2014 |
Co-development of autoimmune hepatitis and Sjögren's syndrome triggered by the administration of herbal medicines.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Azathioprine; Bilirubin; Female; Hepatitis, Autoi | 2013 |
Type 2 autoimmune hepatitis overlapping with primary sclerosing cholangitis in a 10-year-old boy.
Topics: Alkaline Phosphatase; Azathioprine; Biomarkers; Child; Cholagogues and Choleretics; Cholangitis, Scl | 2013 |
Hepatitis C Virus-Autoimmune Hepatitis Overlap Syndrome in an Adolescent.
Topics: Alanine Transaminase; Antibodies, Viral; Aspartate Aminotransferases; Autoantibodies; Azathioprine; | 2015 |
Clinical features of elderly Chinese patients with autoimmune hepatitis.
Topics: Age Factors; Aged; Anti-Inflammatory Agents; Antibodies, Antinuclear; Ascites; Azathioprine; China; | 2013 |
[Onset of severe acute autoimmune hepatitis refractory to conventional treatment, rescued with infliximab].
Topics: Acute Disease; Adult; Antirheumatic Agents; Azathioprine; Drug Substitution; Female; Hepatitis, Auto | 2014 |
Autoimmune hepatitis: trust in transaminases.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Azathioprine; Child; Drug Therapy, Combination; F | 2014 |
Fetal intestinal perforation and meconium peritonitis associated with maternal autoimmune hepatitis.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Azathioprine; Enterococcus faecalis; Female; Gentamicins; | 2014 |
An asymptomatic papulopustular eruption in an immunosuppressed patient.
Topics: Azathioprine; Drug Eruptions; Drug Hypersensitivity; Female; Hepatitis, Autoimmune; Humans; Immunoco | 2014 |
Use of sirolimus in the treatment of refractory autoimmune hepatitis.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Azathioprine; Bilirubin; Drug Resistance; | 2014 |
Dissemination of invasive aspergillosis: diagnostic and management dilemmas.
Topics: Autopsy; Azathioprine; Diagnosis, Differential; Fatal Outcome; Female; Hepatitis, Autoimmune; Humans | 2014 |
Fulminant hepatic failure of autoimmune aetiology in children.
Topics: Adolescent; Age Factors; Alanine Transaminase; Antibodies, Antinuclear; Autoantibodies; Azathioprine | 2015 |
Differences in the adverse effects of azathioprine between inflammatory bowel disease and autoimmune hepatitis in Korean patients.
Topics: Adolescent; Adult; Aged; Azathioprine; Base Sequence; Female; Genotype; Hepatitis, Autoimmune; Human | 2014 |
Mixed connective tissue disease associated with autoimmune hepatitis and pulmonary fibrosis.
Topics: Adult; Azathioprine; Biopsy; Bronchoscopy; Disease Progression; Female; Hepatitis, Autoimmune; Human | 2014 |
Exome sequencing and array-based comparative genomic hybridisation analysis of preferential 6-methylmercaptopurine producers.
Topics: Adult; Azathioprine; Colitis, Ulcerative; Comparative Genomic Hybridization; Crohn Disease; DNA Copy | 2015 |
Characteristics and outcome of autoimmune liver disease in Asian children.
Topics: Adolescent; Anti-Inflammatory Agents; Asian People; Azathioprine; Child; Child, Preschool; Cholangit | 2015 |
Everolimus treatment for patients with autoimmune hepatitis and poor response to standard therapy and drug alternatives in use.
Topics: Adrenal Cortex Hormones; Adult; Alanine Transaminase; Azathioprine; Drug Resistance, Multiple; Evero | 2015 |
Long-Term Prognostic Significance of Persisting Histological Activity Despite Biochemical Remission in Autoimmune Hepatitis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Biomarkers; Biopsy; Drug Administration Schedul | 2015 |
A rare case of type-I auto-immune hepatitis and thyroiditis presenting with crescentic glomerulonephritis.
Topics: Adult; Autoantibodies; Azathioprine; Biomarkers; Biopsy; Drug Therapy, Combination; Female; Glomerul | 2015 |
Autoimmune-like hepatitis during masitinib therapy in an amyotrophic lateral sclerosis patient.
Topics: Adult; Amyotrophic Lateral Sclerosis; Azathioprine; Benzamides; Biopsy; Chemical and Drug Induced Li | 2015 |
Long-term follow-up of patients with difficult to treat type 1 autoimmune hepatitis on Tacrolimus therapy.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Aspartate Aminotransferases; Azathioprine; Cholan | 2016 |
Incidence and Characteristics of Autoimmune Hepatitis.
Topics: Adolescent; Adrenal Cortex Hormones; Azathioprine; Canada; Child; Cholangiopancreatography, Magnetic | 2015 |
Standard Treatment in Adults: Which Steroid? Or without Steroids?
Topics: Adult; Azathioprine; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Mycop | 2015 |
AIH: Which Alternative for Difficult-to-Treat Patients?
Topics: Azathioprine; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Treatment Fa | 2015 |
Treatment Withdrawal in Autoimmune Hepatitis.
Topics: Azathioprine; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Recurrence; | 2015 |
Clinical Characteristics and Prognosis in Children and Adolescents With Autoimmune Hepatitis and Overlap Syndrome.
Topics: Adolescent; Azathioprine; Brazil; Child; Child Health Services; Cholangitis, Sclerosing; Cohort Stud | 2016 |
Successful pregnancy with autoimmune cirrhosis.
Topics: Adrenal Cortex Hormones; Adult; Antihypertensive Agents; Azathioprine; Cesarean Section; Esophageal | 2016 |
Optimize Thiopurine Therapy in Autoimmune Hepatitis.
Topics: Azathioprine; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Mercaptopurine | 2016 |
A real-world study focused on the long-term efficacy of mycophenolate mofetil as first-line treatment of autoimmune hepatitis.
Topics: Adult; Azathioprine; Drug Therapy, Combination; Female; Hepatitis, Autoimmune; Humans; Immunosuppres | 2016 |
Severe transaminitis in a paediatric patient with systemic lupus erythaematosus and a discussion of the literature.
Topics: Adolescent; Azathioprine; Biopsy; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; L | 2016 |
Liver dysfunction and fibrosis as predictors of biochemical response to autoimmune hepatitis treatment.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Azathioprine; Bilirubin; Biomarkers; Cross | 2016 |
Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis.
Topics: Alanine Transaminase; Alopecia; Antibiotics, Antineoplastic; Aspartate Aminotransferases; Azathiopri | 2016 |
Autoimmune hepatitis and long-term disease course in children in Turkey, a single-center experience.
Topics: Adolescent; Age of Onset; Autoantibodies; Azathioprine; Biomarkers; Child; Drug Therapy, Combination | 2016 |
Clinical Overlap of Multiple Sclerosis and Autoimmune Hepatitis: Three Cases.
Topics: Adrenal Cortex Hormones; Adult; Autoantibodies; Autoantigens; Azathioprine; Biopsy; Diagnosis, Diffe | 2016 |
Predictive factors of poor response to therapy in Autoimmune Hepatitis.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Age Factors; Aged; Aged, 80 and over; Alanine Transamina | 2016 |
Arthralgia and Fevers in a Patient With Autoimmune Hepatitis.
Topics: Aged; Arthralgia; Azathioprine; Drug Hypersensitivity; Erythema Nodosum; Exanthema; Fever; Hepatitis | 2016 |
Two Cases of Hepatosplenic T-Cell Lymphoma in Adolescents Treated for Autoimmune Hepatitis.
Topics: Adolescent; Azathioprine; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Neo | 2016 |
The use of tacrolimus in refractory autoimmune hepatitis in children and adults: a single center experience.
Topics: Adolescent; Adult; Azathioprine; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Ma | 2017 |
Autoimmune Hepatitis-related Cirrhosis: Clinical Features and Effectiveness of Immunosuppressive Treatment in Chinese Patients.
Topics: Aged; Asian People; Azathioprine; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; L | 2016 |
Expert clinical management of autoimmune hepatitis in the real world.
Topics: Azathioprine; Biopsy; Budesonide; Cyclosporine; Health Care Surveys; Hepatitis, Autoimmune; Humans; | 2017 |
A national retrospective study of paediatric end-stage liver disease as a predictor of change to second-line therapy in children with autoimmune hepatitis.
Topics: Adolescent; Adrenal Cortex Hormones; Age Factors; Area Under Curve; Azathioprine; Canada; Child; Chi | 2017 |
Autoimmune hepatitis in patients with human immunodeficiency virus (HIV): Case reports of a rare, but important diagnosis with therapeutic implications.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Female; Hepatitis, Autoimmune; HIV Infections; Humans | 2017 |
Outcomes in Pediatric Autoimmune Hepatitis and Significance of Azathioprine Metabolites.
Topics: Adolescent; Azathioprine; Biomarkers; Child; Child, Preschool; Female; Follow-Up Studies; Hepatitis, | 2017 |
The first childhood case with coexisting Hashimoto thyroiditis, vitiligo and autoimmune hepatitis.
Topics: Adolescent; Azathioprine; Glucocorticoids; Hashimoto Disease; Hepatitis, Autoimmune; Humans; Male; P | 2016 |
Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis.
Topics: Adult; Aged; Autoantibodies; Azathioprine; Bile Ducts; Dihydrolipoyllysine-Residue Acetyltransferase | 2008 |
Follow-up of pregnant women with autoimmune hepatitis: the disease behavior along with maternal and fetal outcomes.
Topics: Abortion, Spontaneous; Adolescent; Adult; Azathioprine; Congenital Abnormalities; Female; Hepatitis, | 2009 |
[Optimising azathioprine treatment: determination of thiopurine methyltransferase activity and thiopurine metabolites].
Topics: Adolescent; Azathioprine; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Inflammat | 2009 |
Primary central nervous system lymphomatoid granulomatosis in a patient receiving azathioprine therapy.
Topics: Aged; Antimetabolites, Antineoplastic; Azathioprine; Central Nervous System Neoplasms; Female; Gluco | 2009 |
Meloxicam as a cause of drug-induced autoimmune hepatitis.
Topics: Actin Cytoskeleton; Alanine Transaminase; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-St | 2010 |
[Increased liver values of unknown origin. Also consider autoimmune hepatitis].
Topics: Azathioprine; Diagnosis, Differential; Drug Therapy, Combination; Hepatitis, Autoimmune; Humans; Imm | 2009 |
Management of autoimmune and cholestatic liver disorders.
Topics: Anti-Inflammatory Agents; Azathioprine; Carcinoma, Hepatocellular; Cholagogues and Choleretics; Chol | 2009 |
Immune responses in autoimmune hepatitis: effect of prednisone and azathioprine treatment: case report.
Topics: Adolescent; Azathioprine; CD4 Lymphocyte Count; Cytokines; Female; Glucocorticoids; Hepatitis, Autoi | 2009 |
Autoimmune hepatitis in a demographically isolated area of Australia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Australia; Australian Capital Territory; Azathioprine; C | 2010 |
A case of difficult-to-treat autoimmune hepatitis successfully managed by TNF-alpha blockade.
Topics: Adult; Antibodies, Monoclonal; Azathioprine; Biopsy, Needle; Disease Progression; Drug Therapy, Comb | 2009 |
[Diagnosis and treatment of autoimmune hepatitis].
Topics: Adrenal Cortex Hormones; Aged, 80 and over; Azathioprine; Diagnosis, Differential; Female; Hepatitis | 2009 |
Characterisation and utility of thiopurine methyltransferase and thiopurine metabolite measurements in autoimmune hepatitis.
Topics: Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Biomarkers; Cross-Sectional Studies; Female; Fol | 2010 |
Long-term treatment reduction and steroids withdrawal in children with autoimmune hepatitis: a single centre experience on 55 children.
Topics: Adolescent; Azathioprine; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combi | 2009 |
Long-term treatment outcomes for autoimmune hepatitis in Korea.
Topics: Adolescent; Adult; Aged; Azathioprine; Disease-Free Survival; Drug Therapy, Combination; Female; Hep | 2010 |
Monitoring of azathioprine metabolites in pediatric patients with autoimmune hepatitis.
Topics: Adolescent; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Azathioprine; Biotransformation; Bloo | 2010 |
Iatrogenic immunodeficiency-associated lymphoproliferative disease of the Hodgkin lymphoma-like variant in a patient treated with mycophenolate mofetil for autoimmune hepatitis.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Diagnosis, Diff | 2010 |
Treatment response in patients with autoimmune hepatitis.
Topics: Adult; Azathioprine; Hepatitis, Autoimmune; Humans; Prednisolone; Secondary Prevention; Treatment Ou | 2010 |
Drug-induced postinfantile giant cell hepatitis.
Topics: Adult; Azathioprine; Dietary Supplements; Female; Hair Preparations; Hepatitis, Autoimmune; Humans; | 2010 |
De novo autoimmune hepatitis with centrilobular necrosis following liver transplantation for primary biliary cirrhosis: a case report.
Topics: Azathioprine; Biopsy; Drug Therapy, Combination; Female; Glucocorticoids; Hepatitis, Autoimmune; Hum | 2010 |
Usefulness of the measurement of azathioprine metabolites in the assessment of non-adherence.
Topics: Adolescent; Azathioprine; Child; Child, Preschool; Female; Guanine Nucleotides; Hepatitis, Autoimmun | 2010 |
Reactivation of autoimmune hepatitis during budesonide monotherapy, and response to standard treatment.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Azathioprine; Budesonide; Female; Glucocorticoids | 2011 |
[Histological regression of liver fibrosis with immunosuppressive therapy in autoimmune hepatitis].
Topics: Adolescent; Adult; Aged; Azathioprine; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agen | 2011 |
Azathioprine metabolite measurements are not useful in following treatment of autoimmune hepatitis in Alaska Native and other non-Caucasian people.
Topics: Adult; Alaska; Azathioprine; Biomarkers; Female; Genetic Association Studies; Hepatitis, Autoimmune; | 2011 |
Autoimmune liver disease in patients with systemic lupus erythematosus: a retrospective analysis of 147 cases.
Topics: Adult; Antibodies, Antinuclear; Azathioprine; Biopsy; Enzyme-Linked Immunosorbent Assay; Female; Hep | 2011 |
Azathioprine induced pancreatitis in a patient with co-existing autoimmune pancreatitis and hepatitis.
Topics: Abdominal Pain; Autoimmune Diseases; Azathioprine; Hepatitis, Autoimmune; Humans; Immunosuppressive | 2011 |
[A case of autoimmune hepatitis following acute hepatitis A].
Topics: Acute Disease; Alanine Transaminase; Antibodies, Antinuclear; Aspartate Aminotransferases; Autoantib | 2011 |
Autoimmune hepatitis type 2 in a child with IPEX syndrome.
Topics: Azathioprine; Child, Preschool; Follow-Up Studies; Genetic Diseases, X-Linked; Hepatitis, Autoimmune | 2011 |
Autoimmune hepatitis following Epstein-Barr virus infection.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Diagnosis, Differential; Drug Therapy, Combination; E | 2008 |
Prognostic implications of antibodies to Ro/SSA and soluble liver antigen in type 1 autoimmune hepatitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Antinuclear; Autoantigens; Azathioprine; Dru | 2012 |
British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Cyclosporine; Diagnosis, Differential; Disease Progre | 2011 |
Prurigo nodularis as the first manifestation of a chronic autoimmune cholestatic hepatitis.
Topics: Alkaline Phosphatase; Antibodies, Antinuclear; Azathioprine; Cholestasis; Cyclosporine; Dermatologic | 2011 |
Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1.
Topics: Aged; Alanine Transaminase; Azathioprine; Biomarkers; Carcinoma, Hepatocellular; Cholagogues and Cho | 2012 |
Ornidazole-induced autoimmune hepatitis.
Topics: Adult; Azathioprine; Biopsy; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Fema | 2011 |
Autoimmune hepatitis with anti SLA antibodies.
Topics: Autoantibodies; Autoantigens; Azathioprine; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; | 2011 |
11q23 rearrangement and duplication of MLLT1-MLL gene fusion in therapy-related acute myeloid leukemia.
Topics: Azathioprine; Chromosome Banding; Chromosomes, Human, Pair 11; Cyclosporine; Female; Gene Duplicatio | 2012 |
Clinical significance of azathioprine metabolites for the maintenance of remission in autoimmune hepatitis.
Topics: Administration, Oral; Adult; Aged; Alanine Transaminase; Azathioprine; Cohort Studies; Confidence In | 2012 |
Autoimmune hepatitis: current knowledge.
Topics: Antibodies, Antinuclear; Autoantibodies; Autoantigens; Azathioprine; Child; Cyclosporine; Genetic Pr | 2012 |
Autoimmune hepatitis in children in Eastern Denmark.
Topics: Adolescent; Azathioprine; Biopsy; Child; Child, Preschool; Denmark; Drug Therapy, Combination; Femal | 2012 |
Management of autoimmune hepatitis in children: how many steps away from common agreement?
Topics: Azathioprine; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver; Liver Cirrhosi | 2012 |
A girl with type 1 diabetes and a yellowish appearance.
Topics: Anti-Inflammatory Agents; Autoantibodies; Azathioprine; Child; Diabetes Mellitus, Type 1; Drug Thera | 2010 |
Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Child; Female; Follow-Up Studies; He | 2013 |
Clinical features of autoimmune hepatitis and comparison of two diagnostic criteria in Korea: a nationwide, multicenter study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antibodies, Antinuclear; Autoantibodies; A | 2013 |
Clinical problem-solving. An intricate interplay.
Topics: alpha 1-Antitrypsin; Anti-Inflammatory Agents; Autoantibodies; Azathioprine; Diagnosis, Differential | 2012 |
[Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis].
Topics: Adult; Aged; Azathioprine; Female; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunosuppressive | 2012 |
[Characteristics, diagnosis and therapy of patients with autoimmune hepatitis].
Topics: Anti-Inflammatory Agents; Azathioprine; Delayed Diagnosis; Hepatitis, Autoimmune; Humans; Immunosupp | 2012 |
Epigenetic considerations and the clinical reevaluation of the overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Aspartate | 2013 |
Cyclosporine induced biochemical remission in childhood autoimmune hepatitis.
Topics: Adolescent; Azathioprine; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; | 2012 |
Use of a xanthine oxidase inhibitor in autoimmune hepatitis.
Topics: Allopurinol; Azathioprine; Enzyme Inhibitors; Female; Glucocorticoids; Hepatitis, Autoimmune; Humans | 2013 |
[Erythema gyratum repens: drug reaction following azathioprine administration in a patient with type I autoimmune hepatitis].
Topics: Aged; Azathioprine; Diagnosis, Differential; Drug Eruptions; Drug Therapy, Combination; Female; Hepa | 2002 |
Autoimmune hyperlipidemia in a child with autoimmune hepatitis.
Topics: Adolescent; Autoimmune Diseases; Azathioprine; Child; Drug Therapy, Combination; Female; Hepatitis, | 2002 |
Azathioprine metabolite measurements in the treatment of autoimmune hepatitis in pediatric patients: a preliminary report.
Topics: Adolescent; Adult; Azathioprine; Child; Child, Preschool; Cohort Studies; Female; Hepatitis, Autoimm | 2002 |
[Autoimmune hepatitis].
Topics: Autoantibodies; Azathioprine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug T | 2002 |
Hyperprolactinemia caused by azathioprine.
Topics: Adult; Azathioprine; Female; Hepatitis, Autoimmune; Humans; Hyperprolactinemia; Immunosuppressive Ag | 2003 |
[Erythema gyratum repens. Drug hypersensitivity after azathioprine in a patient with type 1 autoimmune hepatitis].
Topics: Azathioprine; Diagnosis, Differential; Drug Eruptions; Female; Hepatitis, Autoimmune; Humans; Immuno | 2002 |
Histological features associated with relapse after corticosteroid withdrawal in type 1 autoimmune hepatitis.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Biopsy; Female; Follow-Up Studies; Hepatitis, Autoimmu | 2003 |
Autoimmune hepatitis, cryoglobulinaemia and untreated coeliac disease: a case report.
Topics: Anti-Inflammatory Agents; Azathioprine; Celiac Disease; Cryoglobulinemia; Female; Hepatitis, Autoimm | 2003 |
Autoimmune hepatitis type 1 after Epstein-Barr virus infection.
Topics: Azathioprine; Blood Chemical Analysis; Child, Preschool; Drug Therapy, Combination; Epstein-Barr Vir | 2003 |
[Primary biliary cirrhosis and autoimmune hepatitis overlap syndrome: therapeutic features in 5 patients].
Topics: Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Cholagogues and Choleretics; Drug Therapy, Comb | 2003 |
[Autoimmune hepatitis during pregnancy].
Topics: Adult; Autoantibodies; Azathioprine; Budesonide; Female; Hepatitis, Autoimmune; Humans; Immunosuppre | 2003 |
Frequency and significance of antibodies to chromatin in autoimmune hepatitis.
Topics: Adolescent; Adult; Aged; Autoantibodies; Azathioprine; Chromatin; Drug Therapy, Combination; Female; | 2003 |
[The overlap syndrome of autoimmune hepatitis and primary biliary cirrhosis. Clinical and therapeutic analysis of 5 cases].
Topics: Adult; Antibodies, Antinuclear; Autoantibodies; Azathioprine; Cholagogues and Choleretics; Clinical | 2003 |
[Thiopurine methyltransferase activity in patients with autoimmune hepatitis].
Topics: Azathioprine; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Male; Methyltransfera | 2003 |
Testicular ischemia due to intravascular large B-cell lymphoma: a novel presentation in an immunosuppressed individual.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplasti | 2003 |
Autoimmune hepatitis and the antiphospholipid antibody syndrome. A case report.
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Azathioprine; Female; Hepatitis, Autoimmune; Humans; Pred | 2003 |
[Hodgkin's disease during azathioprine therapy in a patient with autoimmune hepatitis].
Topics: Aged; Azathioprine; Female; Hepatitis, Autoimmune; Hodgkin Disease; Humans; Immunosuppressive Agents | 2004 |
Histological changes after the use of mycophenolate mofetil in autoimmune hepatitis.
Topics: Azathioprine; Female; Hepatitis, Autoimmune; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; | 2004 |
Differential efficacy of corticosteroids and interferon in a patient with chronic hepatitis C-autoimmune hepatitis overlap syndrome.
Topics: Adult; Antiviral Agents; Azathioprine; Drug Therapy, Combination; Female; Glucocorticoids; Haplotype | 2004 |
Utility of azathioprine metabolite measurements in post-transplant recurrent autoimmune and immune-mediated hepatitis.
Topics: Azathioprine; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Kidney Transplantation; Monit | 2004 |
Utility of azathioprine metabolite measurements in post-transplant recurrent autoimmune and immune-mediated hepatitis.
Topics: Adolescent; Azathioprine; Child; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Ki | 2004 |
Lower extremity ulceration in an immunocompromised patient.
Topics: Aged; Azathioprine; Cryptococcosis; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunocompromise | 2004 |
Diagnosis and treatment of autoimmune hepatitis at age 65 and older.
Topics: Aged; Antibodies; Antibodies, Antinuclear; Azathioprine; Chronic Disease; Drug Therapy, Combination; | 2005 |
Rapamycin successfully treats post-transplant autoimmune hepatitis.
Topics: Autoantibodies; Azathioprine; Biopsy; Calcineurin Inhibitors; Child; Child, Preschool; Hepatitis, Au | 2005 |
Increased rates of early adverse reaction to azathioprine in patients with Crohn's disease compared to autoimmune hepatitis: a tertiary referral center experience.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Arthralgia; Azathioprine; Crohn Disease; Disease Sus | 2005 |
A fresh look at clinical excellence.
Topics: Azathioprine; Clinical Competence; Diagnosis, Differential; Female; Hepatitis, Autoimmune; Humans; M | 2005 |
Clinical features of type 1 autoimmune hepatitis in elderly Italian patients.
Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Antibodies, Antinuclear; Autoimmune Diseases; Azat | 2005 |
Early treatment response predicts the need for liver transplantation in autoimmune hepatitis.
Topics: Adult; Azathioprine; Canada; Drug Therapy, Combination; Endpoint Determination; Female; Hepatitis, A | 2005 |
Autoimmune hepatitis type 1: safety and efficacy of prolonged medical therapy.
Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; Azathioprine; Drug Therapy, Combination; Femal | 2005 |
Autoimmune hepatitis in India: profile of an uncommon disease.
Topics: Adolescent; Adult; Aged; Antibodies; Antibodies, Viral; Azathioprine; Child; Child, Preschool; Endos | 2005 |
Empiric therapy of autoimmune hepatitis with mycophenolate mofetil: comparison with conventional treatment for refractory disease.
Topics: Adrenal Cortex Hormones; Adult; Aspartate Aminotransferases; Azathioprine; Bilirubin; Biomarkers; Do | 2005 |
Autoimmune thyroiditis associated with autoimmune hepatitis.
Topics: Adolescent; Autoantigens; Azathioprine; Female; Hepatitis, Autoimmune; Humans; Liver; Prednisone; Th | 2005 |
[Autoimmune hepatitis in a patient with uveitis].
Topics: Adrenal Cortex Hormones; Adult; Autoimmune Diseases; Azathioprine; Drug Therapy, Combination; Female | 2005 |
Antibodies to filamentous actin (F-actin) in type 1 autoimmune hepatitis.
Topics: Actins; Adolescent; Adult; Aged; Aged, 80 and over; Autoantibodies; Azathioprine; Biomarkers; Case-C | 2006 |
Remission with ursodeoxycholic acid of type 1 autoimmune hepatitis resistant to azathioprine and steroids.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Cholagogues and Choleretics; Drug Resistance; Female; | 2005 |
Azathioprine use during pregnancy: unexpected intrauterine exposure to metabolites.
Topics: Adult; Azathioprine; Crohn Disease; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; | 2006 |
Thiopurine methyltransferase deficiency and azathioprine intolerance in autoimmune hepatitis.
Topics: Adult; Azathioprine; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Male; Methyltr | 2006 |
Utility of thiopurine methyltransferase genotyping and phenotyping, and measurement of azathioprine metabolites in the management of patients with autoimmune hepatitis.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Drug Monitoring; Female; Genotype; | 2006 |
Frequency and significance of antibodies to cyclic citrullinated peptide in type 1 autoimmune hepatitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Aspartate Aminotransferases; Auto | 2006 |
Azathioprine monotherapy for maintenance of remission in pediatric patients with autoimmune hepatitis.
Topics: Adolescent; Adrenal Cortex Hormones; Alanine Transaminase; Antibodies, Antinuclear; Aspartate Aminot | 2006 |
Persistent elevation of serum alanine aminotransferase levels leads to poor survival and hepatocellular carcinoma development in type 1 autoimmune hepatitis.
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Anti-Inflammatory Agents; Azathioprine; Carcinoma, He | 2006 |
Follow-up of children with autoimmune hepatitis treated with cyclosporine.
Topics: Adolescent; Azathioprine; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; | 2006 |
Autoimmune hepatitis: are we using the right therapy?
Topics: Adolescent; Animals; Azathioprine; Child; Cyclosporine; Disease Models, Animal; Genetic Predispositi | 2007 |
Thiopurine S-methyltransferase gene polymorphism in Japanese patients with autoimmune liver diseases.
Topics: Adult; Aged; Agranulocytosis; Asian People; Azathioprine; Bone Marrow; Female; Gastrointestinal Dise | 2007 |
[Overlap syndrome autoimmune hepatitis and primary biliary cirrhosis associated with antiphospholipid syndrome].
Topics: Adult; Antibodies, Antinuclear; Antiphospholipid Syndrome; Arrhythmias, Cardiac; Autoantibodies; Aut | 2006 |
Alloimmune hepatitis following peripheral stem cell transplantation.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Busulfan; Cyclophosphamide; Female; Graft vs Host Dis | 2007 |
Guidelines for therapy of autoimmune liver disease.
Topics: Animals; Azathioprine; Cholagogues and Choleretics; Cholangitis, Sclerosing; Glucocorticoids; Hepati | 2007 |
[Autoimmune hepatitis in pediatric patients].
Topics: Azathioprine; Child; Child, Preschool; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agen | 2007 |
Development of autoimmune hepatitis in primary biliary cirrhosis.
Topics: Adult; Alanine Transaminase; Anti-Inflammatory Agents; Aspartate Aminotransferases; Azathioprine; Ch | 2007 |
Cryptococcal meningitis after Imuran (azathioprine) therapy for autoimmune hepatitis.
Topics: Adult; Azathioprine; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Male; Meningitis, Cryp | 2007 |
Impact of gender on the long-term outcome and survival of patients with autoimmune hepatitis.
Topics: Adult; Age of Onset; Analysis of Variance; Anti-Inflammatory Agents; Autoantibodies; Azathioprine; E | 2008 |
Re: Azathioprine monotherapy for maintenance of remission in pediatric patients with autoimmune hepatitis.
Topics: Adolescent; Adrenal Cortex Hormones; Azathioprine; Child; Cholagogues and Choleretics; Hepatitis, Au | 2007 |
Giant cell hepatitis in a teenage woman.
Topics: Adult; Azathioprine; Biopsy; Female; Giant Cells; Glucocorticoids; Hepatitis, Autoimmune; Humans; Im | 2008 |
[Autoimmune hepatitis and pregnancy: about a patient's three consecutive pregnancies].
Topics: Adult; Autoantibodies; Azathioprine; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents | 2008 |
[Elevated liver enzymes in rheumatoid arthritis : differential diagnostic considerations based on a case report].
Topics: Adalimumab; Adolescent; Alanine Transaminase; Antibodies, Monoclonal; Antibodies, Monoclonal, Humani | 2008 |
Acute diarrhea during azathioprine treatment of type I autoimmune hepatitis.
Topics: Acute Disease; Aged; Azathioprine; Diarrhea; Female; Hepatitis, Autoimmune; Humans; Immunosuppressiv | 2008 |
[Non hodgkin's lymphoma associated with chronic auto-immune hepatitis treated with azathioprine].
Topics: Antimetabolites, Antineoplastic; Azathioprine; Female; Follow-Up Studies; Hepatitis, Autoimmune; Hep | 2008 |
An atypical presentation for primary sclerosing cholangitis.
Topics: Adrenal Cortex Hormones; Adult; Autoimmune Diseases; Azathioprine; Cholangiography; Cholangitis, Scl | 1997 |
[Chronic hepatitis. 7: Therapy of autoimmune liver diseases].
Topics: Azathioprine; Dose-Response Relationship, Drug; Drug Administration Schedule; Hepatitis, Autoimmune; | 1997 |
Autoimmune hepatitis in older patients.
Topics: Aged; Autoantibodies; Azathioprine; Female; Follow-Up Studies; Hepatitis, Autoimmune; Humans; Immuno | 1997 |
De-novo autoimmune hepatitis after liver transplantation.
Topics: Anti-Inflammatory Agents; Autoantibodies; Azathioprine; Child; Female; Graft Survival; Hepatitis, Au | 1998 |
Is severe cryptogenic chronic hepatitis similar to autoimmune hepatitis?
Topics: Adult; Autoantibodies; Azathioprine; Biopsy, Needle; Chronic Disease; Diagnosis, Differential; Femal | 1998 |
[Autoimmune hepatitis: importance of budesonide in intolerance to prednisolone].
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Azathioprine; Budesonide; Drug Therapy, Combinati | 1999 |
Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis.
Topics: Abatacept; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antigens, CD; Antig | 2000 |
[Autoimmune hepatitis complicated by intolerable pain of lower extremities and shock due to azathioprine].
Topics: Adult; Azathioprine; Drug Hypersensitivity; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive | 2000 |
Azathioprine-induced lung toxicity and efficacy of cyclosporin A in a young girl with type 2 autoimmune hepatitis.
Topics: Adolescent; Autoantibodies; Azathioprine; Cyclosporine; Female; Hepatitis, Autoimmune; Humans; Immun | 2000 |
Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine.
Topics: Adolescent; Adult; Alanine Transaminase; Anti-Inflammatory Agents; Azathioprine; Dose-Response Relat | 2000 |
Management and outcome of pregnancy in autoimmune hepatitis.
Topics: Adolescent; Adult; Azathioprine; Chi-Square Distribution; Female; Follow-Up Studies; Hepatitis, Auto | 2001 |
[Azathioprine and cavum carcinoma in a patient with autoimmune hepatitis and Crohn's disease].
Topics: Azathioprine; Carcinoma, Squamous Cell; Crohn Disease; Head and Neck Neoplasms; Hepatitis, Autoimmun | 2001 |
The spectrum of chronic autoimmune hepatitis.
Topics: Adolescent; Adult; Autoantibodies; Azathioprine; Biopsy, Needle; Chronic Disease; Female; Hepatitis | 1998 |
Long-term management and prognosis of autoimmune hepatitis (AIH): a single center experience.
Topics: Adolescent; Adult; Aged; Azathioprine; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; F | 2001 |
Autoimmune liver disease in children.
Topics: Adolescent; Azathioprine; Biomarkers; Child; Child, Preschool; Female; Hepatitis, Autoimmune; Humans | 2001 |
Posttransplant immune hepatitis in pediatric liver transplant recipients: incidence and maintenance therapy with azathioprine.
Topics: Adolescent; Alanine Transaminase; Aspartate Aminotransferases; Azathioprine; Child; Child, Preschool | 2001 |
Autoimmune hepatitis.
Topics: Adolescent; Alanine Transaminase; Anti-Inflammatory Agents; Azathioprine; Biomarkers; Child; Female; | 2001 |
Autoimmune hepatitis in African Americans: presenting features and response to therapy.
Topics: Adult; Age of Onset; Azathioprine; Black or African American; Cohort Studies; Drug Therapy, Combinat | 2001 |
Therapeutic effects of azathioprine in combination with low-dose prednisolone in patients with intractable autoimmune hepatitis type 1.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Dose-Response Relationship, Drug; Drug Therapy, Combi | 2001 |
Systemic lupus erythematosus related transverse myelitis presenting longitudinal involvement of the spinal cord.
Topics: Adult; Autoimmune Diseases; Azathioprine; Brain; Cyclophosphamide; Drug Resistance; Facial Nerve Dis | 2002 |
Incidence and recurrence of autoimmune/alloimmune hepatitis in liver transplant recipients.
Topics: Adult; Azathioprine; Cyclophosphamide; Female; Graft Rejection; Graft Survival; Hepatitis, Autoimmun | 2002 |
Estrogen and cyproterone acetate combination-induced autoimmune hepatitis.
Topics: Adolescent; Androgen Antagonists; Anti-Inflammatory Agents; Azathioprine; Cyproterone Acetate; Drug | 2002 |
Budesonide as first-line therapy for non-cirrhotic autoimmune hepatitis in children: a decision analysis.
Topics: Adolescent; Anti-Inflammatory Agents; Budesonide; Child; Child, Preschool; Decision Support Techniqu | 2016 |
Complete regression of cirrhosis after immunosuppressive treatment in autoimmune hepatitis.
Topics: Child; Endoscopy, Digestive System; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; | 2008 |
Allopurinol safely and effectively optimises thiopurine metabolites in patients with autoimmune hepatitis.
Topics: Adult; Aged; Alanine Transaminase; Allopurinol; Antimetabolites; Drug Interactions; Drug Therapy, Co | 2013 |